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ABSTRACT 
In order to prevent sickness absence and to maintain a safe and sound work climate, 
interventions may be needed in the workplace. Occupational Health Services (OHS) are 
special advisers, with the opportunity to suggest/perform interventions at individual and 
group level. The use of methods for evaluating changes in health is a precondition when 
assessing that such interventions are meaningful and successful. The aim of this thesis is to 
study markers of general stress as indicators of changes in the risk of negative health effects, 
which are feasible when evaluating interventions at group as well as at individual level. Sleep 
disorders are common in conjunction with stress, and are also associated with negative health 
effects. Sleep has been investigated in this thesis using: (1) a questionnaire assessing global 
sleep (during the last six months) (studies I and II); (2) self-reported sleep during one or 
several specific nights of interest (in a sleep diary) (studies III and IV); (3) objectively 
measured sleep with an actigraph (study IV).  Heart rate variability during sleep is another 
potential marker, and is examined in study III. Study I and study II are five-year prospective 
studies investigating sleep as a predictor of: (I) sickness absence in three groups with 
different pain conditions, and (II) change in number of pain sites between baseline and 
follow-up. Study III is a cross-sectional twin study investigating self-reported stress during 
the day and changes in heart rate variability, heart rate and self-reported sleep quality the 
subsequent night. Further, study III investigated whether individual factors related to genes 
and/or familial environment had an effect on the associations between stress and heart rate 
variability/heart rate and stress and self-reported sleep quality. In study IV, repeated objective 
and subjective sleep measurements during seven consecutive nights were performed. The 
measurements took place in a workplace, i.e., under conditions translatable to an OHS 
setting. The number of consecutive measurements that are needed for a reliable sleep 
measure, and the correlation between subjective and objective sleep measures, are 
investigated in this study.  
Sleep disturbances were found to be an indicator of increased risk of sickness absence during 
five-year follow-up within all the three pain groups that presumably represent three different 
levels of wellbeing at baseline (study I). Further, sleep was an indicator of change in number 
of self-reported pain sites between baseline and the five-year follow-up. Associations 
between perceived daytime stress and changes in heart rate variability, heart rate, and self-
reported sleep quality the subsequent night were seen in study III. The results of study III 
further indicate that these associations are influenced by individual factors related to genes 
and/or the familial environment. In study IV, it was shown that subjective (sleep quality) and 
objective (sleep efficiency) measures correlate poorly on a day-by-day basis, which indicates 
that objective and subjective sleep may capture different dimensions of sleep. If only week 
nights are included in repeated sleep measurements, fewer measurements are needed to 
obtain a reliable measure of sleep as compared with when weekend nights are included. In all, 
measurements of sleep are easier to use than measurements of heart rate variability, which 
makes sleep a more realistic marker, especially when considering larger groups.              
SAMMANFATTNING 
För att förebygga sjukskrivning och främja ett säkert och hälsosamt arbetsklimat kan 
interventioner behöva göras på arbetsplatser. Företagshälsovården (FHV) har med sin 
specialistkompetens möjlighet att föreslå/driva interventioner av sådant slag. Att använda 
utvärderingsmetoder som mäter förändring av hälsoläget är en förutsättning för att värdera 
om sådana interventioner är meningsfulla och framgångsrika. Syftet men denna avhandling 
var att studera markörer för generell stress som indikatorer för förändring i risk för negativa 
hälsoeffekter, som kan vara användbara vid utvärdering av interventioner. Sömnbesvär är 
vanligt förekommande i samband med stress och även kopplat till negativa hälsoeffekter. 
Sömn har undersökts (1) med ett frågeformulär som mäter sömn globalt (under de senaste sex 
månaderna) (studie I och II); (2) självrapporterad sömn under specifika nätter (sömndagbok) 
(studie III och IV); (3) objektivt uppmätt sömn med aktigraf (sömnklocka) (studie IV).  
Hjärtfrekvensvariabilitet under sömn är en annan möjlig användbar objektiv stressmarkör, 
vilken undersökts i studie III. I studie I och II har självrapporterade sömnbesvär undersökts i 
longitudinella studier med 5-års uppföljning som indikatorer för risk för sjukskrivning (studie 
I) och förändring av antal självrapporterade smärtlokalisationer (studie II) bland individer 
grupperade efter smärttillstånd vid basmätningen. Studie III är en tvärsnittstudie som 
undersökt självrapporterad stress under dagen och skillnader i hjärtfrekvensvariabilitet och 
hjärtfrekvens (under sömn) och självrapporterad sömnkvalitet under nästföljande natt bland 
tvillingar. Vidare undersöktes i studie III om sambandet mellan upplevd stress och 
hjärtfrekvensvariabilitet/hjärtfrekvens och sambandet upplevd stress och sömnkvalitet 
påverkades av faktorer som är relaterade till gener och/eller gemensam uppväxtmiljö. Studie 
IV är en metodstudie där upprepade objektiva och subjektiva sömnmätningar under sju 
sammanhängande nätter, utförts. Mätningarna utfördes på en arbetsplats, dvs. under 
förhållanden som liknar de som är verklighet för en FHV. I studien undersöks hur många 
nätters mätning som krävs för ett reliabelt mått på sömn, hur mätningar påverkas av att 
inkludera helgnätter samt korrelationer mellan objektivt och subjektivt uppmätt sömn. 
Resultaten visade att sömnbesvär indikerade ökad risk för sjukskrivning under en 
femårsperiod inom alla tre smärtgrupperna som antogs representera tre olika nivåer av 
välmående vid basen (studie I). Sömn indikerade även sannolikheten att fem år efter 
basmätningen rapportera förändrat antal smärtlokalisationer. I studie III sågs ett samband 
mellan upplevd stress under dagen och skillnader i hjärtfrekvensvariabilitet, hjärtfrekvens och 
självrapporterad sömnkvalitet (sömndagbok) nästföljande natt. Resultaten från studie III 
indikerar vidare att effekten påverkas av individuella faktorer relaterade till gener och/eller 
uppväxtmiljö. I studie IV där upprepade sömnmätningar studerades korrelerade subjektivt 
(sömndagbok) och objektivt (sömnklocka) uppmätt sömn dåligt vilket i enighet med tidigare 
studier indikerar att objektiv och subjektiv sömn mäter olika dimensioner av sömnbesvär. Om 
enbart vardagar inkluderades i de upprepade mätningarna krävdes färre dagars mätning för att 
få ett reliabelt mått på sömn. Sömnmätningar är en enklare metod att använda och tolka än 
hjärtfrekvensvariabilitet vilket gör sömn till en mer realistisk markör att använda, framförallt 
på större grupper.   
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ANS Autonomic Nervous System 
CI Confidence Interval 
CWP Chronic Widespread pain 
DZ Dizygotic 
HF High Frequency  
HR Heart Rate 
HRV Heart Rate Variability 
IBI Inter Beat Intervals 
LBP Low Back Pain 
LF Low Frequency  
MZ Monozygotic 
NSP Neck Shoulder Pain 
OHS Occupational Health Services 
OR Odds Ratio 
PNS Parasympathetic Nervous System 
RMSSD Root Mean Squares of Successive Differences between 
adjacent normal-normal intervals  
RSA Respiratory Sinus Arrhythmia 
SDNN Standard Deviation of Normal-Normal intervals 
SNS Sympathetic Nervous System 
VLF Very Low Frequency  
  
  
  
  
  
  
   
1 
1 INTRODUCTION 
In Sweden in 2012, 5% of women and 3% of men aged 20-64 reported their health to be bad 
or very bad. The proportion with sickness absence was in 2012 just above 2% 
1
. The two 
most common causes of receiving sickness cash benefits in Sweden today (sickness absence 
of more than 14 consecutive days) are musculoskeletal pain and psychological ill-health, and 
together they represent approximately 60% of all individuals receiving sickness cash 
benefits
2
.   
In a survey investigating work-related disorders in the working population in Sweden in 
2014, self-reported data on sickness absence and work-related disorders were assessed (i.e., 
all sickness absence, not only sickness absence of >14 consecutive days). Of the individuals 
who were absent from work due to sickness at the time of interview, 26% of women and 21% 
of men reported work-related disorders as a cause of (self-reported) sickness absence 
3
.  
Stress is one of the most common work-related causes of complaints 
3
. Diminished 
psychological wellbeing and musculoskeletal pain commonly co-occur, and decreased 
psychological health is associated with the prognosis of musculoskeletal pain 
4, 5
. Moreover, 
work stress has been shown, inter alia, to be associated with elevated risk of incident 
coronary heart disease and stroke 
6
. Including a measurement of stress when evaluating health 
in a workplace would be highly relevant.  
One of the important tasks of Occupational Health Services (OHS) as special advisers is to 
prevent ill-health in the workplace, e.g., by different types of interventions to maintain a safe 
and sound work environment. OHS have the opportunity to suggest interventions for a 
favorable workplace, for an individual employee with special needs, and also for the entire 
staff to prevent overall illness or accidents in the workplace. For OHS to be successful in 
evaluating the overall condition of employees in a workplace, it would be beneficial to have 
markers that indicate changes in wellbeing and potentially increased risk of reduced 
workability.     
The term “stress” as it is used today was coined by Hans Selye in 1936 who defined it as: 
“the non-specific response of the body to any demand for change”. Stress, or strain, is often 
described as the overload of different body systems after continuous response to stressors 
7, 8
. 
The term is problematic since it may refer to different aspects of stress, such as stress as an 
exposure (stressful living), as the outcome/effect (strain as a body response to stress), or as an 
intermediate factor (e.g., as a factor related to vulnerability to stress) affecting the relationship 
between exposure and outcome. Further, exposures inducing stress can be of both a 
psychological (e.g., worry, anxiety) and a physical (e.g., injury, disease, or musculoskeletal 
pain) nature.  
There are individual differences in how people respond to or tolerate different types of stress 
7
. When including measures of stress as indicators of changes in health in a population, it 
would therefore be relevant to include a marker of general stress that indicates increased risk 
 2 
of diminished wellbeing as a complement to subjective ratings of stress and ratings of the 
magnitude of the stress exposure.  
Sleep disturbances are one such potential marker, indicating a non-beneficial stress response. 
Supressed sleep is a common consequence of increased activity in stress systems 
9
, and self-
rated sleep disturbances and self-rated stress are closely related 
10
. Further, sleep problems 
have been shown to be associated with sickness absence 
11, 12
 and pain 
13-15
. Sleep is also 
appealing as a marker from the perspective of clinical feasibility since it can be measured 
rather easily, both subjectively (by administering a questionnaire) and objectively (e.g., by 
actigraph).  
Another potentially objective marker, to be used as a complement to subjective ratings of 
stress, is heart rate variability (HRV). HRV is a widely used non-invasive objective method 
for measurement of the activation of autonomic nervous system in stress research. Further, 
HRV is associated with a range of health effects. Depressed HRV has been shown to predict 
mortality and arrhythmic complications after acute myocardial infarction, and is also an early 
sign of diabetic neuropathy 
16
. Reduced vagal activity during sleep has also been seen among 
persons with fibromyalgia 
17
. It has also been shown to predict self-reported sleep problems 
among individuals with chronic fatigue syndrome 
18
.  
In this thesis, sleep disturbance and HRV are investigated as feasible potential markers of 
general stress, indicating change in wellbeing and risk of sickness absence.    
 
 
 
 
 
 
 
 
 
 
  
 
 
   
3 
2 BACKGROUND 
2.1 SICKNESS ABSENCE AND WORK ABILITY 
The number of individuals receiving sickness benefit has fluctuated over the years 
2
. The 
statistics in figure 1 describe sickness benefit cash disbursed by Sweden’s Social Insurance 
Agency. In Sweden, employees with sickness absence of more than 14 consecutive days 
receive their cash sickness benefit from the Insurance Agency. During years 1997 and 2003 
however, there were temporary changes in the legislation, and the employer was made 
responsible for disbursing sick pay for the first 28 and 21 days, respectively. In 2008 new 
stricter rules regarding disability pension were introduced.  
Musculoskeletal disorders and psychological illnesses jointly represent approximately 60% of 
registered diagnoses for sickness benefit, and are by far the two most common groups of 
diagnoses. In recent years, the proportion of cases of sickness absence due to diagnoses 
related to psychological illness has increased. In 2005, musculoskeletal disorders represented 
29.3%, and psychological illness 28.9% of all diagnoses. In 2014, musculoskeletal disorders 
represented 21.5%, and psychological illnesses 39.5% of registered diagnoses, as a cause of 
sickness benefit. Among women, psychological illnesses were the most prevalent cause of 
sickness absence as early as in 2005, and in 2011 they became the most common cause 
among men 
2
 (fig. 2).  
There has also been an increase in the prevalence of sleeping problems. In Sweden, it doubled 
from 1980 to 2012. The prevalence in 2012 was 32% among women and 21% among men 
1
.   
Many individuals with a musculoskeletal diagnosis also have a psychological diagnosis. It is 
therefore not clear whether it is an actual increase in psychological ill-health that is seen in 
the statistics, or whether it is the culture among physicians, who choose which diagnosis to 
put as the cause of sickness absence, that has changed.    
The most commonly occurring self-reported reasons for complaints in the Swedish working 
population in 2014 were back pain, sleep disturbances and distress/anxiety/depression. Stress 
was the most common work-related cause of complaints in Sweden in 2014, followed by 
strenuous working postures 
3
.   
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Figure 1. Number of ongoing cases of receipt of sickness cash benefit in Sweden in December in years 
1992 to 2014. Stratified by gender. Source: The Swedish Social Insurance Agency 
2
.  
 
 
Figure 2. Percentages of ongoing cases (percentages of men and women) of cash sickness 
benefit in Sweden in December (years 2005 to 2014), diagnosed with ICD codes F00-F99 
(Mental and behavioural disorders) and M00-M99 (Diseases of musculoskeletal system and 
connective tissue). Stratified by gender and diagnose. Source: The Swedish Social Insurance 
Agency 
2
.   
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5 
2.2 STRESS   
The phenomenon of stress can be described as an overload of bodily systems after repeated 
exposure to stressors that puts strain on the systems maintaining homeostasis. Prolonged 
exposure to stress has been shown to be associated with several mental and physical 
conditions, including cardiovascular events 
19
. A recent review concluded that work stressors, 
such as job strain and long working hours, are associated with moderately elevated risks of 
incident coronary heart disease and stroke 
6
. 
The acute activation of physiological systems during stress is a natural reaction, and prepares 
the body to respond adequately to the stressor. Allostasis is a term that describes the ability of 
physiological (stress) systems to increase or decrease vital organ functions to attain a new 
steady state. This is achieved mainly by activation of the autonomic nervous system (ANS) 
and the hypothalamic-pituitary-adrenal (HPA) axis. Allostatic load describes the strain on the 
body produced by repeated ups and downs in physiological responses 
7, 20, 21
.   
The ANS is a key stress regulatory system that has effects on peripheral organs via centres in 
the central nervous system. The periphery systems of the ANS constitute the sympathetic 
nervous system (SNS) and the parasympathetic nervous system (PNS). The SNS and PNS 
constantly interact, which enables dynamic modification of bodily states as responses to 
changes in the environment. Increased activity in the SNS increases cardiac output and 
facilitates motor activity, whereas activity in the PNS promotes recovery processes, lowers 
blood pressure and heart rate, and increases gut movements 
22
.  
Stress refers to an exposure (external or internal stress stimuli), an outcome (the strain on 
bodily stress systems), and the intermediates influencing the relationship between the 
stressful exposure and the strain on the body (e.g., individual vulnerability).    
There are individual differences in how we respond to or handle stress. These differences 
have been generally explained by: 1) individual differences in perceptions or interpretations 
of the situation potentially causing stress, and 2) the condition of the body itself 
7
. Resilience 
is a term that is used to describe reduced vulnerability to risk exposure when experiencing a 
relatively good outcome, despite stressful or adverse experiences 
23, 24
.   
One aspect of importance when discussing stress responses associated with negative health 
effects may be how individuals respond differentially to the prolonged activity of stress 
systems, e.g., with disturbed sleep. Bonnet and Arand 
25
 identified individuals responding 
with sleep disturbances by comparing baseline sleep with sleep across different stressful 
situations, including caffeine intake, first-night sleep in a laboratory, and having their sleep 
time advanced by three or six hours. The group of individuals responding to the stressful 
situation with poor sleep also showed increased sympathetic activity 
25
.  
Sleep reactivity to stress has been shown to be 43% heritable among men and 29% among 
women 
26
, which entails that heritability factors  may be one explanatory mechanism behind 
individual differences in vulnerability to insomnia. Further, FIRST scores (sleep reactivity) 
 6 
and insomnia have been shown to share genetic influences, which  implies that sleep 
reactivity may mark a genetic vulnerability to developing insomnia 
26
.  
2.2.1 Markers of general stress with potential negative health effects 
Most research measuring physiological stress response objectively has focused on acute 
effects during stress 
27
. Even though the evidence for health effects as a consequence of 
prolonged activation of physiological stress systems is still modest 
27
, it is likely that markers 
indicating sustained activation of stress systems are of importance when estimating the long-
term effects of stress.  
When looking for markers of general stress with potential negative health effects, it is 
important that the investigatory method employed captures changes in the effects of everyday 
life stressors. It is of further importance that the markers are feasible in the field.  
Sustained physiological effect after stress is discussed in a review by Brosschot, which 
investigated markers of chronic stress 
27
. In the review, perseverative cognition, describing 
rumination on the past and worry about the future, is presented as a potential mediator of the 
prolonged effect of stressors on physiology and development of disease 
27
. Further perceived 
stress or worry when going to bed has been shown to be associated with subsequent 
polysomnography-measured sleep disturbances 
28
. 
Another review, by Pieper and Brosschot 
29
, contains a discussion of the reactivity model. 
The model suggests that individuals responding to stress with increased cardiovascular 
reactivity have an increased risk of developing cardiovascular disease. In this review, it is 
suggested that the duration, rather than the magnitude, of the stress response may be 
important when estimating the risk of cardiovascular disease 
29
. Markers of stress showing a 
prolonged physiological stress response during sleep may be important indicators of stress 
with potential negative health effects.  
Sleep and recovery have been shown to be important for many body functions, including 
immunological defence and health maintenance 
30
. Further, sleep disturbances have been 
shown, inter alia, to predict mortality 
31
, acute myocardial infarction 
32
, and sickness absence 
11, 12, 33-45
. The onset of impaired sleep has also been shown to predict adverse changes in 
health-related behaviours, such as weight control, smoking, use of alcohol, and physical 
inactivity 
46
. Moreover, sleeping problems have been shown to mediate the association seen 
between organizational justice and employee ill-health 
47
, which implies that sleep 
disturbances may be an important factor in the relationship between work-related stress and 
ill-health. 
A recent study by Åkerstedt and colleagues 
48
 found that higher work demands predicted 
disturbed sleep two years later. Further, sleep disturbances at baseline predicted subsequent 
higher work demands, perceived stress, less social support, and lower degree of control two 
years later 
48
. Also, de Lange and colleagues 
49
 investigated the effect of the (rather well-
established) work stress indicator, from the demand/control/support model 
50
, and found that 
   
7 
a change from a low strain job to a high strain job over a period of three years was associated 
with increased sleep problems at follow-up 
49
.  All this suggests that sleep may be a feasible 
marker of stress, indicating an increased risk of negative health effects. Sleep has the further 
advantage of being relatively easy to measure in the field, both subjectively and objectively 
(e.g., with an actigraph).  
Primary insomnia has been shown to be associated with physiological arousal, including 
higher activation of the SNS and an elevated heart rate during sleep 
51
, and it has been argued 
that reactivity is a key individual factor in vulnerability to insomnia 
52
. When studying sleep 
in individuals free from insomnia but with high scores on sleep reactivity tests (FIRST
1
) after 
stress, those with high ratings on stress reactivity had significantly lower sleep quality and 
physiological hyperarousal 
53
. In line with other studies, this indicates that there are 
individual differences in vulnerability to transient insomnia, and that vulnerability is 
associated with physiological hyperarousal 
25, 51, 53, 54
.  Further, vulnerability to insomnia 
(high sleep reactivity) has been shown to be associated with an elevated risk of developing 
persistent insomnia among good sleepers 
54
.    
Including an objective marker of stress with potential negative health effects would be 
valuable as a complement to subjective ratings when evaluating interventions. In addition to 
sleep, one potential marker may be heart rate variability (HRV), which is a non-invasive 
measure of activity in the autonomic nervous system (ANS). Several types of stress have 
been shown to be associated with sustained cardiovascular effects (by altered HR, HRV or 
blood pressure) during sleep 
29
. 
It has been suggested that imbalance in the ANS is a link in the pathway between 
psychological ill-health and somatic disease 
55
, and that altered HRV is one possible 
explanatory mechanism behind the increased risks of mortality and medical morbidity 
associated with depression among patients with coronary heart disease 
56
.  
In experimental settings, acute effects on night time HRV have been seen among individuals 
manipulated into stressful tasks during the day (compared with controls) 
57
, and also among 
children playing violent video games 
58
. 
In studies where stress exposure is not induced experimentally, altered night time HRV has 
been shown to be associated with, for example, daily worry 
59
, fibromyalgia 
17
 chronic fatigue 
syndrome 
18
, and prolonged daytime sleepiness (lasting >3 months) among irregular shift 
workers  
60
.  
Both sleep and HRV during sleep have the potential of being a feasible marker of 
physiological stress response of a longer duration. Moreover, both markers are associated 
with ill-health, which made them interesting to investigate further in this thesis.      
                                                 
1
 FIRST: the Ford Insomnia Response to Stress Test, which measures perceived vulnerability to symptoms 
of situational insomnia after stressful situations. 
 
 8 
2.2.2 Sleep measurements 
Sleep can be measured objectively or subjectively. The most commonly used methods for 
objective measurements are polysomnography and actigraphy. Polysomnography is a 
comprehensive method, with which brain activity (EEG), muscle activity (EMG), eye 
movement (OEG), heart rhythm (ECG) and respiratory air flow may be assessed. Actigraphy 
is a simpler form of sleep measurement, which registers the gross motor activity from which 
estimates of sleep-wake patterns can be made. The advantage of actigraphy is that it is easy to 
use (an actigraph is designed as a wrist watch, and attached as such), and reasonably easy to 
access data from. Commonly used parameters measured by actigraphy are sleep duration, 
sleep latency (time from going to bed to falling asleep), wake after sleep onset (awakenings 
during the night), and sleep efficiency (percentage of sleep period with actual sleep). 
Actigraphy has shown good validity when validated against polysomnography.  In laboratory 
studies, epoch-by-epoch sleep estimates have been shown to have correlations of at least 0.85 
in normal individuals 
61
. The main source of criticism in validity studies has been its ability to 
detect wake if the subject is lying very still, resulting in underestimations of sleep latency and 
wake after sleep onset 
62
.  
There are several questionnaires available for assessing sleep subjectively.  In sleep 
questionnaires, items related to different dimensions of sleep, including sleep latency, 
awakenings during nights and self-rated sleep quality, are assessed with reference to how 
sleep usually has been during a certain period of time. Another commonly used form of 
questionnaire is a sleep diary, assessing sleep on a daily basis, where the items refer to the 
preceding night.  
Studies investigating the correlation between subjective and objectively measured sleep have 
had inconsistent results 
63-71
, and a substantial portion of non-laboratory studies show rather 
low agreement overall 
64, 67-69, 71, 72
. In a review of studies of breast cancer survivors, it was 
found that sleep onset latency was typically overestimated, and that sleep quality was 
typically underestimated, by subjective sleep measures as compared with objective measures 
73
. The overall low agreement implies that the subjective and objective measures capture 
different dimensions of sleep 
72, 74
.  It has been found that going to bed late, use of 
medications, being in employment, higher body mass index (BMI), increased daylight hours, 
and longer menstrual cycles are associated with poorer objective (actigraphic) sleep, and that 
unemployment and perceived stress are  associated with poorer subjective sleep quality 
75
. 
Another study, using Actiheart to assess objective sleep, found that subjective sleep 
efficiency was associated with over-commitment, low level of social support and poorer self-
rated health, whereas objective sleep measures were not 
74
. This study, however, used 
objectively recorded sleep data from one week night and one leisure night only, and a 
subjective measure referring to sleep problems over the last month 
74
. The intra-individual 
day-by-day variance in objective sleep parameters has been found to be large 
76
. The limited 
body of research investigating how many nights of measurement are needed  for a reliable 
sleep measure to be obtained suggest that at least five nights are required when performing 
measurements on children and adolescents 
77
, at least three nights for a reliable measure of 
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sleep efficiency among women 
75
, and at least five nights for sleep duration in an adult 
population including males and females 
76
.    
2.2.3 Heart rate variability 
Heart rate variability (HRV) can be used as a “probe” to reflect responses to stress in central 
regulatory systems. The rhythm of the heart is modulated by innervation from both the SNS, 
associated with energy mobilization, and PNS, associated with vegetative and restorative 
functions. The activities of the two systems are in dynamic balance, but they can be rapidly 
modulated in response to changing environmental demands 
78
.  HRV is based on the two 
systems (sympathetic and parasympathetic) having antagonistic effects on the rhythm of the 
heart (inter-beat intervals, IBI, or R-R intervals), and that there is a constant fluctuation of 
rhythm. It has been found that discrepancies in time between activation and inhibition 
correspond to the different autonomic systems, and that cardiac response to SNS activity is 
slower than response to PNS (vagal) activity.  The most prominent parasympathetic 
modulated fluctuation of the beat-to-beat interval in young healthy individuals is respiratory 
sinus arrhythmia (RSA) 
79
.   
Two principal domains are used for analyzing HRV, the time domain, and the frequency 
domain. In time-domain analysis, heart rate (HR) is treated as a mean for a certain recording 
epoch, and the standard deviation of the mean as a measure of HRV. Four time-domain 
parameters have been recommended in the Task Force report (1996). Two of these estimate 
overall HRV: a) the standard deviation of all normal (NN) intervals (SDNN), and b) the 
triangular index. A third estimate is:  c) the standard deviation of the average NN interval 
(SDANN), which estimates the long-term components of HRV. And, fourth, there is: d) the 
root mean square of successive (beat) differences (RMSSD), which estimates the short-term 
components of HRV 
16
. Both the SDNN and the RMSSD have been shown to be useful 
indices of vagal activity 
78
. The frequency domain involves transforming IBI data into 
different frequency patterns by spectral analyses using the fast Fourier transform technique 
(FFT), or auto-regression techniques (AR). The three main parameters from frequency-
domain analyses estimate power from very low frequencies (VLF, ≤0.04 Hz), low 
frequencies (LF, 0.04-0.15 Hz,), and high frequencies (HF, 0.15-0.4 Hz) 
16, 79
. It is rather well 
established that HF power primarily reflects parasympathetic influences. It has been 
suggested that LF power reflects both parasympathetic and sympathetic activity, but the 
physiological meaning and interpretation of LF and the LF/HF ratio (interpreted as an 
estimate of sympathovagal balance) are currently under debate 
80, 81
. It has also been 
suggested that thermoregulation and vasomotor activity are two activities that are reflected by 
VLF power 
82
, but little is known about the specific physiological process attributable to VLF 
power, and the existence of such a process has been questioned 
16
.  
Overall, despite these uncertainties, lower values on these indices of vagal function have been 
shown to be associated prospectively with mortality and disability in several studies 
78
. 
Further, alterations in HRV have been shown to be associated with diabetes 
83
, arrhythmic 
events and sudden cardiac death after acute myocardial infarction 
84
.  Thus, regardless of the 
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difficulties in interpreting specific physiological processes attributable to the different HRV 
parameters, alterations in HRV in conjunction with intervention may capture changes 
relevant to health effects.    
2.3 MUSCULOSKELETAL PAIN AND STRESS 
Pain has been defined by the International Association for the Study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage”. This definition is the most widely used 85.   
Musculoskeletal pain is often described as either acute (duration of less than 6 weeks), sub-
acute (6-12 weeks), or chronic (>3 months).  
Even if studies differ in their estimates of the prevalence of low back pain, LBP (a review of 
studies published between 1966 and 1998 reported a LBP life-time prevalence of 11-80%, a 
point estimate of 12-33%, and a one-year prevalence of 22-65% 
86
), it is considered to be 
common and recurrent 
87, 88
.  
In approximately 85% of cases with LBP complaints it is not possible to diagnose a 
pathoanatomical cause of the pain, which is commonly referred to as non-specific LBP 
89
, 
and symptoms of LBP are poorly associated with radiographic findings 
90
.     
Diminished psychological wellbeing,  such as depressive symptoms 
91, 92
 and stress 
93
, have 
been shown to increase the risk of decreased work ability and sickness absence in individuals 
with musculoskeletal pain.  Also, concurrency of pain from multiple sites 
91, 94-96
 has been 
shown to increase the risk of sickness absence. 
Localised pain and pain from multiple sites may reflect different types of conditions. Having 
pain from several sites is more common than having localised pain. As compared with having 
pain from a single site, pain from several sites has been shown to be a stronger predictor of 
sickness absence 
94, 95, 97
, disability pension 
98
, and decreased work ability 
99
. A linear 
relationship has been seen between number of pain sites and functional ability 
100
. Moreover, 
number of pain sites has shown an almost linear relationship to reduction in overall subjective 
health, sleep disturbances and psychological health in a general Norwegian population 
101
. 
Number of painful locations has further been shown to be more strongly associated with 
health-related functioning than chronicity or location of the pain 
102
. 
The term multisite or multiple-site musculoskeletal pain refers to pain from several body 
sites, concurrently or within a specified period of time. The concept is relatively new and 
lacks a clear definition. Multisite pain differs from the more widely studied phenomenon of 
chronic widespread pain (CWP) in several aspects.  According to the definition of CWP 
developed by the American College of Rheumatology, it represents pain in two contralateral 
quartiles of the body, above and below the waist and in the axial skeleton, and the pain should 
have been present for at least three months 
103
.  The term multisite pain, however, usually 
describes pain from multiple sites, irrespective of location or chronicity.   
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How to identify individuals at risk of developing chronic conditions is a challenging task for 
caregivers. The complexity behind the pain phenomenon challenges researchers to find the 
key factors associated with prognosis, so as to provide an answer to the “holy grail type of  
questions” (as phrased in the Cochrane Back Review Group): “Which interventions are most 
efficient for which type of patients?”, and “Which are the most important prognostic 
factors?”104.      
To suggest that psychological factors interplay with pain perception is neither new nor 
controversial. In 1965, Melzack and Wall presented the gate control theory of pain. The 
theory suggests that there is a gate regulating the transmission and intensity of nerve signals 
in the dorsal horn of the spinal cord. The authors propose that sensation from a pain stimulus 
is  inhibited by conflicting activity in larger fibres (Aβ fibres) transmitting signals for non-
painful stimuli  
105
. Even though the theory has been questioned in more recent research, 
suggesting that the modulation of pain perception by non-painful stimuli also occurs in the 
brain  
106
, gate control theory is regarded as important for understanding the complex 
phenomenon of pain, taking both psychological and sensory phenomena into consideration. It 
suggests, for example, that psychological factors (e.g., past experience, attention and 
emotion) influence perception by acting on the control system 
105, 107
.  
The biopsychosocial model of pain integrates the individual`s physiological, biological, 
cognitive, affective, behavioural, and social attributes. The model  suggests that chronic pain 
should signal to the clinician that there is something wrong in the patient`s life, and that  the 
origin of the problem is either biological, psychological or social, and that psychosocial 
factors play an increasing role in pain behaviour as the duration of the pain lengthens 
107
.  
In a review of studies of LBP and NSP by Linton and colleagues 
5
 it was found that 
psychological factors clearly had an impact on the transition from acute to chronic pain 
disability.  Passive coping, pain cognitions (e.g., catastrophizing), fear-avoidance beliefs, 
depression, anxiety, distress and self-perceived poor health were the most evident 
psychosocial predictors of pain (LBP/NSP) and disability found in the review 
5
. More recent 
longitudinal studies have suggested that belief that LBP will last for a long time, pain 
intensity 
108
, not being in employment 
109, 110
, work absence, long duration of pain, high 
function disability, high pain intensity, anxiety, poor self-rated health 
109
, high risk according 
to a psychological screening questionnaire, high emotional distress 
111
, catastrophizing, 
widespread pain, and high level of chronic pain grade 
110
 are all predictors of poor LBP 
prognosis.  
Increased knowledge about the impact of psychosocial factors on the prognosis of 
musculoskeletal pain has generated multiple questionnaires for practitioners and researchers 
to use for risk estimation (yellow flags), and for the evaluation of individuals with 
musculoskeletal pain, and LBP and NSP in particular. The Subgroup for Targeted Treatment 
(STarT) 
112
, the Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) 
113, 114
, the 
LBP Patient Perception Scale (PPS) 
115
, and the Multidimensional Pain Inventory (MPI) 
116
 
are some examples.  
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2.4 SLEEP AND PAIN 
Sleep disturbances are common in individuals with musculoskeletal pain 
13, 117
, and it has 
been well demonstrated that pain and sleep are related 
13, 15
. A recent study of LBP patients 
assessed pain (LBP) and sleep once a week over a six-month period. It was seen in the study 
that a week with more days of bothersome pain was typically followed by a week with more 
days of (pain-related) sleep disturbances 
117
.  
The direction of causality between sleep and pain is, however, not entirely clear, albeit it is 
most likely reciprocal 
14, 15, 118, 119
.  One of the studies that supports the theory of a 
bidirectional relationship is a recent large investigation that found that self-reported insomnia, 
sleep onset latency and sleep efficiency were associated with increased pain sensitivity 
120
, 
which is in line with previous findings from smaller studies 
121, 122
.  Another relatively large 
study found that sleep duration (<6 or >9 hours) was associated with greater next-day pain 
123
.  In long-term prospective studies, sleep disturbances have been shown to predict 
fibromyalgia (10 year follow-up) 
124
, and chronic pain (17-year follow-up) 
125
, and good sleep 
quality has been shown to predict the resolution of widespread pain (15-month follow-up) 
126
.  
Further, a recent review presents a trend showing sleep disturbances to be a stronger 
predictive factor for pain than vice-versa 
118
.  
The mechanisms explaining the relationship between pain and sleep are not yet entirely 
understood.  Several potential mechanisms are discussed in a recent review by Finan and 
colleagues
118
. According to the authors, an influence of sleep deprivation on dopamine with a 
potential effect on concurrent changes in pain sensitivity may be one of the explanatory 
mechanisms. Another pathway discussed is diminished opioid analgesia following sleep 
disruption. Further, the impact of negative affect is discussed, and it is suggested that sleep, 
pain and negative mood have shared variance. However, the authors report a lack of research 
explaining the dynamics of the associations. Also, the moderating effects of 
sociodemographic factors, such as (female) gender and (older) age, on the relationship 
between sleep disturbances and pain are discussed as potential mechanisms 
118
.      
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2.5 HYPOTHETICAL MODEL 
The purpose of this thesis, to investigate markers of stress as predictors of wellbeing and 
workability, is based on the assumptions presented in the hypothetical model below (fig. 3).  
External exposure is here meant to refer to exposure to stressors in a broad sense, including, 
for example, a change in workplace environment, having musculoskeletal pain, or being 
exposed to other physical or psychosocial stressors. Being exposed to various stressors is 
presumed to induce an individual risk of change in wellbeing. It is hypothesised that a marker 
of (general) stress indicates change in risk of decreased wellbeing (e.g., worse pain or 
sickness absence), at both group and individual level.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A hypothetical model of how markers of stress may indicate risk of change in wellbeing and 
risk of sickness absence.   
 
 
 
 
 
External exposure (e.g., physical 
or psychosocial stressors or pain) 
Change in risk of decreased 
wellbeing 
No change/ 
increased 
wellbeing 
Decreased workability  
(Sickness absence) 
Decreased 
wellbeing 
Markers of 
(general) stress
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3 AIMS OF THE THESIS 
3.1 OVERALL AIM 
The overall purpose of this thesis was to study markers of general stress as early indicators of 
change in strain. Such markers would be feasible measures to include when evaluating health 
outcomes at group as well as at individual level in conjunction with interventions in clinical 
settings and in workplaces. The markers of stress are investigated as potential predictive 
markers of change in wellbeing and workability.   
3.2 SPECIFIC AIMS 
The aim of study I was to investigate whether self-reported sleep disturbances predicted 
sickness absence among individuals with, and without, LBP and/or NSP. The study is a five-
year prospective study.  
 
The aim of study II was to investigate whether sleep predicts the onset and resolution of 
multisite pain in a five-year prospective perspective.  
 
In study III, the aim was to study whether everyday life stress was captured by changes in 
HRV during sleep and self-reported sleep quality the subsequent night. Further, the impact of 
factors related to genetic or familial similarities on such associations were investigated. The 
study is a cross-sectional twin study.   
 
The aim of study IV was to describe objective and subjective sleep assessments and to 
investigate how many nights of consecutive sleep measurements are required to obtain a 
reliable sleep measure. 
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4 MATERIAL AND METHODS 
4.1 DATA SOURCES 
Studies I and II are based on the MUSIC-Norrtälje study. Data for study III were assessed in 
collaboration with a longitudinal hearing study of twins (TWINHEAR), and data for study IV 
were assessed as a part of the SHIP study. 
4.1.1 The MUSIC Norrtälje Study 
The MUSIC (Musculoskeletal Intervention Center)-Norrtälje study was initiated to identify 
and quantify risk and protective factors, and to investigate the prognosis, for low back and 
neck-shoulder disorders. The study was designed as a case referent study at baseline with 
five-year follow-up. Register data on sickness absence was obtained from the National Social 
Insurance Agency and linked to the 2329 individuals who participated at both baseline and 
follow-up.    
The baseline case-referent study was based on a sample from a study population that 
embraced 17,000 men and women, 20-59 years-old, living and working in the rural 
municipality of Norrtälje. People in the study population who had sought care or treatment 
for nonspecific low back and/or neck-shoulder pain during the study period January 1
st
 1994 
to June 30
th
 1997 from any of the approximately 70 caregivers in the region, including not 
only physicians and physiotherapists but also other caregivers such as chiropractors, 
osteopaths and homeopaths, were defined as cases. The caregivers asked their patients if they 
wanted to participate in the study, but they did not record refusals. Thus, the rate of potential 
participants who refused to join the study is unknown. According to interviews with the 
caregivers, only a few refused to take part. A random sample of referents, stratified by sex 
and age in five-year categories, were selected through the population register. At least one 
referent per case was selected. Only cases and referents who had not sought care or treatment 
for low back or neck-shoulder pain during the six months preceding their enrolment were 
included in the study. The rate of referents who participated was approximately 69% 
127, 128
.  
Demographic and individual data concerning low back pain (LBP), neck-shoulder pain 
(NSP), other non-musculoskeletal disorders, psychological wellbeing, and physical and 
psychosocial work-related exposures were assessed through self-administered questionnaires 
and structured interviews at baseline. Clinical examinations were also performed 
129, 130
.   
At follow-up, four to six years after the baseline study, a self-administered postal 
questionnaire was sent out to all participants (cases and referents) who were still living in 
Sweden. Data concerning LBP, NSP, non-musculoskeletal disorders, diminished 
psychological wellbeing, and physical and psychosocial work-related exposures were 
assessed using items similar to those in the baseline study. Those who entered the baseline 
study in 1994-1995 received their follow-up questionnaires in year 2000, and those who 
entered in 1996-1997 in 2001. 28% received their follow-up questionnaire six years after 
entering the baseline study, 68% five years from baseline, and 4% four years from baseline. 
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The response rate was 83% (n=2329). Among the non-responders, there were higher 
proportions of males and participants younger than 45 
129
. Further, register data concerning 
sickness absence (sickness benefit and disability pension) were received yearly from the 
National Social Insurance Agency from 1995 to 2001 and linked to each participant. The 
sickness benefit data included number of sick spells per year, number of days per year, and 
partial or full benefit. Data concerning disability pension consisted of the date for newly 
allowed disability pension, and partial or full benefit. Data did not include the diagnosis 
issued by the physician on the sickness certificate, so no information on the reason for 
registered sickness absence was available 
94
. 
4.1.2 Study III 
Participants in study III, investigating stress, heart rate variability (HRV) and sleep quality, 
were recruited through collaboration with a hearing study of twins (TWINHEAR). The 
hearing study was designed as a follow-up to a previous hearing study 
132
 carried out between 
1991 and 1995. The participants for the original twin hearing study were recruited through 
the Swedish Twin Registry 
131
. For inclusion in the original study, both members of a twin 
pair should be male and living in Stockholm or Uppsala County, and there should be a twin 
registry classification of their zygosity. In all, 1629 twins born between 1914 and 1958 were 
identified for invitation to the study, and after drop-out due, for example, to refusal to 
participate, major disease, death or emigration, 1114 individuals took part in the original 
hearing study 
132
. 
The follow-up study was performed from 2010 to 2013. The 1114 individuals who had 
participated in the original study were approached for the follow-up study.  By the time of 
follow-up, 219 individuals had died. Out of the 895 remaining twins, 583 participated in the 
follow-up TWINHEAR study 
133
. 
All individuals who participated in the follow-up hearing study were considered for inclusion 
in cross-sectional study III, for which additional data concerning stress, heart rate variability 
and sleep quality were assessed. For a participant to be included in the additional study, he 
should: 1) not have a pacemaker, 2) have his hearing examined by audiologists on the project, 
and 3) be physically and mentally able to remove and restore the equipment used for HRV 
measurements. Since the study primarily was a sub-study of the hearing study, as well as 
participants being willing to participate in the additional study, time available also influenced 
whether researchers and the participants found it possible to conduct the necessary HRV 
measurements.  
Data for study III were collected between September 2010 and March 2013. In all, 206 HRV 
measurements were performed of which 7 had too much noise in the data, so 199 HRV 
measurements were eligible for further analysis. The 199 individuals included in the study 
were all male monozygotic or dizygotic twins between 52 and 77 years-old. Zygosity was 
based on DNA typing 
134
.   
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4.1.3 The SHIP study 
The participants in the SHIP study (Study of a Health Intervention Programme) were working 
within correctional treatment at an institution in Sweden. In all, 259 individuals who were 
working at the correctional institution in November 2012 were invited to participate in the 
SHIP study. The study was launched in connection with the start-up of an intervention 
focusing on promoting health among the staff, and was carried out by Occupational Health 
Services (OHS). It was a longitudinal study with yearly follow-up. In all, data were assessed 
at three (yearly) time points, the most recent in early spring 2015. The aim of SHIP was to 
evaluate health effects in connection with the start-up of the intervention, and on a yearly 
basis during/after implementing the intervention, and also to elaborate methods for the 
evaluation of health effects feasible for OHS in general. The questionnaires distributed within 
the frame of SHIP included items on several indicators of (ill) health, such as symptoms of 
depression and anxiety, sleep, organizational justice, workability, and self-rated health.  
Of the individuals who joined SHIP, 60 (men and women) were approached for participation 
in a sub-study including additional yearly sleep measurements with an actigraph and a sleep 
diary for seven consecutive nights. The invited individuals were chosen to represent three 
different areas of the workplace. The underlying assumption was that these three groups 
would represent different degrees of stress in the everyday work situation. In addition, the 
participants included for additional sleep measurements were not to work night shifts during 
the study period in conjunction with the days/nights of measurement. Data from the SHIP 
study and the sub-study were assessed in winter/early spring in years 2013, 2014 and 2015. 
Study IV is based on data from assessments at baseline. Of the 60 individuals invited to 
participate in the sub-study at baseline, 58 agreed to take part.  
4.2 MAIN VARIABLES IN STUDY I 
4.2.1 Definitions of LBP and NSP 
The definitions of LBP and NSP were based on items in the baseline questionnaire, which 
covered both pain intensity and pain-related disability. Items concerning pain intensity and 
pain severity from The Severity of Chronic Pain Questionnaire by Korff and colleagues was 
used 
135
. The three items concerning LBP intensity and NSP intensity, respectively, covered: 
(1) current pain, (2) worst pain experienced during the previous 6 months, and (3) average 
pain during the previous 6 months. The three items concerning LBP-related and NSP-related 
disability covered how much the pain had affected: (1) everyday activities, (2) social and 
family activities, and (3) ability to work (including domestic work).  
The ordinal rating scale for the items ranged from 0 to 10, where 0 meant no pain/disability at 
all and 10 meant pain/disability as bad as it can be. A pain intensity score for each participant 
and each of the two body regions was constructed by calculating the mean values of the three 
items that concerned pain intensity 
136
. A pain-related disability score was constructed in the 
same manner as the pain intensity score. Hence, the pain intensity score and the pain-related 
disability score both ranged between 0 and10. A participant was defined as having LBP or 
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NSP if he/she had a pain intensity score ≥3 and/or a pain-related disability score ≥1 in the 
body region in question 
94, 130
. These cut-off points were based on the distribution in the 
cohort of all 2329 subjects who participated at both baseline study and five-year follow-up 
(n= 2329) in the MUSIC-Norrtälje study. About one-third of the subjects had a pain score ≥3 
and/or a pain-related disability score ≥1. Using these cut-off points in the present study, the 
prevalence of LBP only was 16%, and of NSP only 12%, proportions that are in line with 
earlier population studies 
87, 137
. The prevalence of concurrent LBP and NSP was 21%. These 
levels of pain and pain-related disability were considered appropriate levels of pain, i.e., 
levels where it was still possible for the participants to be able to work (since the outcome 
considered in study I was sickness absence). 
4.2.2 Definitions of sleep disturbances 
Data regarding sleep disturbances were obtained using the self-administered Karolinska Sleep 
Questionnaire, which uses a five-item Likert scale 
138
. Five questions, with a single stem, 
were used to form an index for sleep disturbances 
138
: During the last six months have you 
had/experienced … 1) Difficulties falling asleep? 2) Repeated awakenings with difficulties 
going back to sleep? 3) Not being well rested on awakening? 4) Premature awakening? 5) 
Disturbed/restless sleep? There were five response options: 1. Never; 2. Seldom/a few times 
per year; 3. Sometimes/several times per month; 4. Mostly/several days per week; 5. 
Always/every day. Cronbach`s alpha for the index was 0.77.  
The distribution of the sleep scores enabled division of the cohort into tertiles, with total 
scores ranging between 5 and 25. The first tertile (Sleep A, indicating best sleep) scored ≤10, 
the second (Sleep B) 11-13, and the third (Sleep C, indicating worst sleep) ≥14.  
4.2.3 Definitions of sickness absence 
Data on sickness absence were obtained from a register held by the Swedish Social Insurance 
Agency, which received data on the number of days an individual had drawn sickness benefit. 
To be entitled to benefit from the Insurance Agency, the sickness absence had to be >14 
consecutive days. During the period 1
st
 January 1997 to 1
st
 April 1998, the number of 
consecutive days required for sickness benefit from official health insurance was 28 (due to a 
temporary change in legislation). A participant was considered to have been absent due to 
sickness if he/she had received partial or full sickness benefit or disability pension from the 
Agency for at least one period during the years between baseline and follow-up. 
Long-term sickness absence was defined as >180 days of absence entitled to sickness benefit 
or disability pension during at least one one-year period between baseline and follow-up. 
Days with partial benefit were recalculated into full days 
94
.  
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4.3 MAIN VARIABLES IN STUDY II 
4.3.1 Definition of sleep disturbances 
Sleep disturbance was assessed and defined in the same manner as in Study I (see section 
4.2.2).  Again, the three sleep tertiles, Sleep A, indicating best sleep, Sleep B, and Sleep C, 
indicating worst sleep were used to define different levels of sleep disturbances. 
4.3.2 Definition of multisite pain 
Multisite pain was defined using items from a modified version of the Standard Nordic 
Questionnaire 
139
: Have you had discomfort (pain, ache, discomfort) at any time during the 
last six months from: 1) neck; 2) shoulder/shoulders; 3) elbow/elbows; 4) 
hand/hands/wrist/wrists; 5) upper back (thoracic); 6) lower back; 7) hip/hips; 8) knee/knees; 
9) foot/feet? We made no distinction between unilateral and bilateral pain, entailing, for 
example, that if pain was reported from both elbows, the two elbows were treated as just one 
pain location. Thus, the total number of pain locations was nine.  
The same items for assessment of pain sites were used at both baseline and follow-up. In both 
questionnaires, the questions were supplemented with an illustration of the body parts in 
question. The expression “multisite pain” has been used in other studies 98, 140, but with 
different specifications of how many sites should, in general, form a cut-off. The cut-off used 
in study II (≥3 sites) is based on the results of a study by Kamaleri and colleagues, using the 
same questionnaire. In that study, individuals with three or more pain sites were found to 
show an increased risk of work disability 
98
. To establish whether the same cut-off was 
reasonable for study II, a binary logistic regression analysis of sickness absence (of >14 
consecutive days at any time during the five-year study period) was made with numbers of 
pain sites as independent factors, adjusted for age and gender. The analysis showed an OR of 
1.9 (p=0.001) at the level of three pain sites (for two pain sites: OR=1.4, p=0.04; and for four 
pain sites: OR=3.0, p=0.000). 
4.4 MAIN VARIABLES IN STUDY III 
The assessment of HRV data was performed over approximately 24 hours, starting when the 
participants came to the Division of Audiology at Karolinska Institutet, Stockholm, for 
hearing examination by the audiologists. The twins arrived at their pre-booked appointment 
either in pairs or alone, depending on what suited them best. In addition to the audiometry, 
assessments of blood pressure, weight and length for BMI, and attachment of the Actiheart 
device (for HRV measurement) were performed. The participants also received a 
questionnaire including items on perceived stress during the day, to be completed before they 
went to bed at night, and a sleep diary for them to fill in after awakening the subsequent 
morning. The appointment times varied between 8.00 a.m. and 6.00 p.m., and the visit lasted 
between one and two hours. The participants were not given any restrictions regarding 
performing any activities, and they slept at home. They were told to keep the device for HRV 
measurement on until the subsequent morning.      
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4.4.1 Stress 
Perceived stress during the day was assessed by the question: “Have you felt stressed today?” 
(responses on a visual analogue scale, ranging from “not at all” [score 0] to “maximum 
stress” [score 100]).  Due to its skewed distribution, the stress variable was transformed into 
logarithmic units. 
Health-related stress is a potential daily stressor that may not necessarily be acknowledged as 
stress by the people affected. Hearing disability and tinnitus have been shown to be 
associated with long-term stress 
141
. Data on hearing disabilities and tinnitus were available 
due to collaboration with the twin hearing study which gave us an opportunity also to 
investigate influences from the two health-related stressors. Hearing loss was measured by 
audiologists, and pure tone average thresholds (PTA4s) were obtained by calculating the 
mean values of decibel hearing loss measured for frequencies 500, 1000, 2000 and 4000 Hz. 
PTA4s for the better and worse ear were used in the analysis. The assessment of hearing 
disability is described in greater detail by Bogo and colleagues 
133
.  Tinnitus was assessed by 
the single question: “Have you suffered from tinnitus today?” (responses on a visual analogue 
scale, ranging from “not at all” [score 0] to “maximum discomfort” [score 100]). 
The variables derived from VAS scoring (perceived stress and perceived tinnitus) were log-
transformed in order to obtain approximately normal distributions 
4.4.2 Sleep quality 
Sleep quality was assessed using the Karolinska Sleep Diary 
70, 142
 , which was filled in upon 
awakening. A sleep quality sum index 
142
 was constructed on the basis of responses to 
questions in four categories: (1) Sleep quality “How did you sleep?” [very well (5) – very 
poorly (1)]; (2) Restless sleep [not at all (5) – very restless (1)]; (3) Difficulties falling asleep 
[not at all (5) – very difficult (1)], and (4) premature (final) awakening [not at all (5) – woke 
up far too early (1)]. The same index has previously shown to be correlated (0.49- 0.66) with 
objectively sleep efficiency (measured by polysomnograph) 
69, 70
. Sleep quality index scores 
ranged from 4 to 20, where score 4 indicated the worst sleep quality, and score 20 the best 
quality.  
4.4.3 Heart rate and heart rate variability 
Heart rate (HR) and HRV were measured using an Actiheart (Actiheart, Cambridge 
Neurotechnology, Ltd., Papworth, UK) with a sample frequency of 128 Hz. The device, 
tested for reliability and validity 
143
, samples data through two electrodes, one at the sternum 
(by costae 4), and one attached approximately 10 cm laterally (on the left-hand side of the 
chest) from the first electrode. Before recordings started, a signal test was performed, where 
the individual was asked to stand up and move his arms for approximately one minute. If the 
recording was noisy, the electrodes were re-positioned and the signal was tested again. This 
procedure was repeated until a satisfactory signal was obtained. The participant was 
instructed to keep the device on until the subsequent morning. A three-hour data window for 
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nocturnal HRV was selected, starting 30 minutes after self-reported sleep start (assessed in 
the sleep diary). For subjects who did not report any time for sleep start (n=13), a window 
between 01 a.m. and 04 a.m. was selected.  
The method is based on recording regular QRS complexes, defining the R-peak, and 
measuring the RR intervals between (i.e., the inter-beat intervals, IBIs). Fluctuation in the 
lengths of the RR intervals, mirroring activation and inhibition of the regulatory systems, was 
analyzed in spectral analyses (autoregressive) that integrated the power spectrum from three 
frequency bands: very low frequency (VLF) <0.04 Hz; low frequency (LF) 0.04 to <0.15 Hz, 
and high frequency (HF) 0.15 to <0.40 Hz.  From the time-domain analysis, the parameters 
RMSSD (the square root of the mean squared differences between successive NN intervals) 
and SDNN (the standard deviation of the NN interval) were used in study III. All cyclical 
components responsible for variance in heart rate are reflected by SDNN, whereas the 
RMSSD estimates show high frequency variations in heart rate 
144
. The spectral analysis and 
time-domain analysis were performed in a software program 
145
 that uses linear interpolation 
to filter ectopic beats and noise. Data were analyzed in five-minute epochs in accordance with 
Task Force recommendations 
144
. 
The HRV variables were log-transformed in order to obtain approximately normal 
distributions.   
4.5 MAIN VARIABLES IN STUDY IV 
Measurements with actigraph and sleep diaries were performed for seven consecutive nights 
at some point between 4
th
 of February and 6
th
 of March 2013.  
4.5.1 Self-rated sleep 
Self-rated sleep was measured by the Karolinska Sleep Diary 
70, 142
 for the seven consecutive 
nights. In the same manner as in study III (see section 4.4.2), a sleep quality sum index 
142
  
was constructed. Sleep quality sum index scores range from 4 to 20, where score 4 indicates 
worst sleep quality and score 20 best sleep quality.   
4.5.2 Objectively measured sleep 
A wrist-worn actigraph, Motionwatch 8 (Camntech® Ltd), was used for objective sleep 
measurements in study IV. The Motionwatch actigraph has a tri-axial accelerometer capable 
of sensing motions in a resultant force range between 0.01g and 8g. It registers total motor 
gross activity, to be analysed in a software program for sleep-wake analysis. Participants 
were instructed to wear the watch on their non-dominant wrist, day and night for seven 
consecutive days. Recording was made at one-minute epochs.  
Several studies have investigated the validity of the actigraph for sleep measurements. In a 
review from 1995, approved by the American Sleep Disorder Association, it was concluded 
that epoch-by-epoch sleep estimated by actigraphic measurements in laboratory studies had a 
correlation with polysomnographic measurements of at least 0.85 in normal individuals 
61
.  
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The software program, Actiwatch Activity & Sleep Analysis, CamNtech® Ltd version 7.38, 
was used for sleep-wake analysis. A medium sensitivity level was used for estimation of 
sleep-wake patterns. Time for bed was estimated by data from the sleep diary, and entered 
into the sleep analysis software. The software program then calculated when sleep started for 
the night and when sleep ended in the morning. If there was a poor fit between what was 
reported in the sleep diary and what was registered by the actigraph, or if data on time for bed 
and/or time for awakening were missing in the diary, sleep start was estimated by the 
researcher by finding the time when the activity count was lower than 40 for at least five 
minutes, and sleep end when the activity count was higher than 40 for at least ten minutes.  
The objective sleep parameters investigated in Study IV were as follows: 
Actual sleep (%) is a percentage of actual sleep time (assumed sleep minus wake time) and 
was used as an additional parameter for sleep efficiency. Actual sleep derives from 
calculations on the total period between sleep start and sleep end, minus wake periods during 
the night.  
Sleep efficiency (%) describes actual sleep time (assumed sleep time minus wake time) 
divided by time in bed. Thus, by contrast with the actual sleep parameter, calculation of sleep 
efficiency also includes sleep latency. 
Sleep duration represents the total period of time between sleep start and sleep end.  
The fragmentation index derives from addition of percentage minutes moving (number of 
minutes moving/sleep duration) and percentage minutes immobile (number of immobile 
phases of 1 minute as a proportion of the number of immobile phases).  
4.6 SUBJECTS 
The data sources used in the studies included in the thesis are described in table 1.  
 
Table 1. Number of subjects, proportion women and men and mean age of the participants in studies 
I-IV.   
 Study I 
(MUSIC) 
Study II 
(MUSIC) 
Study III Study IV 
(SHIP) 
Subjects (n)
 
2286 1599 199 54 
Women/Men (%) 61/59 60/40 0/100 46/54 
Mean age (range) 42 (20-60) 41 (20-60) 65 (52-77) 45 (26-63) 
 
 
   
23 
4.6.1 Study I 
From the 2329 who participated in the MUSIC-Norrtälje study, individuals who had missing 
data on LBP, NSP or sleep disturbances (n=43) were excluded. 2286 individuals were 
included in Study I. The participants were stratified into three groups: (1) No LBP or NSP; 
(2) Solely LBP or NSP; (3) Concurrent LBP and NSP.   
In all, 90% of the cohort included in Study I were: (a) Working now and the last 12 months, 
(b) Working now, but not throughout the last 12 months, (c) Working at some point during 
the year, but not the last 8 weeks. The working groups contrasted with the remaining 10%, 
who were: (d) Unemployed for the last year, or (e) Not working.    
All participants in Study I were treated as one cohort, regardless of whether they had been 
included as a case or a referent in the MUSIC-Norrtälje baseline study. Of the 2286 
individuals who participated in study I, 41% had been included as cases in the MUSIC-
Norrtälje study.  
4.6.2 Study II 
Study II is also based on data from the MUSIC-Norrtälje study, from baseline and follow-up. 
In the baseline questionnaire, the participants were asked to state whether they had: (1) 
vascular pain from legs; (2) disease of the nerves (brain, spinal cord, peripheral nerves); (3) 
joint reconstruction (arthroplasty) in hip, knee or other joint; (4) any congenital defect in 
joints, muscles or back; (5) been diagnosed with rheumatoid arthritis; and (6) been diagnosed 
with ankylosing spondylitis (Bechterew’s disease). If the response was ‘yes’ to any one of 
these items, the individual was excluded from the study (resulting in exclusion of 10% of the 
cohort). The cohort included all subjects (n=1599) with valid data at baseline and follow-up 
not reporting any of the medical conditions above. 
The cohort was stratified into three groups from baseline data: (1) No pain; (2) Pain from 1-2 
sites; (3) Multisite pain (pain from ≥3sites).  
Out of the 1599 individuals included, 38% had been included as a case in the original 
MUSIC-Norrtälje study.  
4.6.3 Study III 
Of the 199 men included in the study, there were 70 full twin pairs, and 59 participants were 
included as singletons. Of the full pairs, 47 were monozygotic (MZ) twins, and 23 dizygotic 
(DZ). The mean age was 65 (range 52-77), which was somewhat lower than that of the 583 
included in the TWINHEAR study (mean age: 67; range: 52-95).  
Three different sets of analysis were performed in the study, of either the full group or only 
the full twin pairs. In all analyses where HR and HRV were outcomes, only individuals not 
using medications potentially affecting heart rate were included (for SEM, however, the 
analysis was performed both including and excluding participants using the medications). In 
all, 169 individuals did not take medications.  
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For analytic set 1, linear associations between all the dependent and independent variables 
were tested, for both the full group and for the full twin-pair group separately. For the within-
pair analyses in set 2, only full twin pairs were included. Only the independent variables that 
showed significant associations (stress) with the outcomes in set 1 were tested. For SEM, 
performed on set 3, the full group (including singletons) was included. In the cases of HR and 
HRV, SEM analyses were performed both including and excluding individuals using 
medications potentially altering heart rate.  
4.6.4 Study IV 
The 54 individuals in study IV came from the 58 on whom objective sleep measurements had 
been performed. They were the ones who remained after excluding: (a) those who did not 
have at least three days of valid objectively measured sleep data (n=2),  and (b) those who 
had reported that they had been out of bed most of/all the night (n=2). All participants in 
study IV were working at the same correctional institution in Sweden. The invited individuals 
were chosen to represent three different groups in the workplace: (1) those working with 
tasks that involved daily/constant contact with prison inmates (27 participants, 13 women and 
14 men); (2) those with working tasks with no direct or no constant contact with prison 
inmates (13 participants, 6 women and 7 men); (3) those working with tasks with no contact 
with prison inmates at all (14 participants, 6 women and 8 men).  The underlying assumption 
was that these three groups would have different degree of stress in their everyday work 
situation. In addition, the participants included for additional sleep measurements were not to 
work night shifts during the study period in conjunction with the days/nights of measurement. 
Eleven of the participants were working during the weekend.  
4.7 METHODS 
4.7.1 Study I 
In study I, the aim was to explore the influence of self-reported sleep disturbances on future 
sickness absence among individuals with LBP and/or NSP.  This was achieved by logistic 
regression analysis. Previous research has found that having both LBP and NSP is associated 
with higher risk of sickness absence than having pain from either the lower back or 
neck/shoulder, or having no LBP or NSP 
94
. Under these assumptions, analyses were 
performed for the three different strata: (1) No LBP or NSP; (2) Solely LBP or NSP; (3) 
Concurrent LBP and NSP. The effect of level of sleep disturbances on sickness absence was 
tested within each group, with the best sleepers acting as referents within each stratum.  
Two different outcomes for sickness absence were used in the study: (1) sickness absence 
(>14 consecutive days) at any period between baseline and follow-up; (2) long-term sickness 
absence (>180 days) during at least one of the five one-year periods between baseline and 
follow-up.  
The confounders considered were age, gender, other physical illnesses (including 
cardiovascular, respiratory, gastrointestinal, urogenital, and metabolic diseases), regular 
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physical activity, and smoking. Physical activity and smoking did not affect the associations 
and were dropped as confounders in the subsequent analysis.   
4.7.2 Study II 
In study II, the aim was to investigate whether sleep disturbances predict the onset of 
multisite pain 5 years later among individuals free from pain at baseline, and whether good 
sleep predicts the resolution of multisite pain five years later. 
Three groups were formed based on number of pain sites: (1) no pain; (2) pain from 1-2 pain 
sites; (3) pain from ≥3 pain sites (defined as multisite pain). Through multinomial logistic 
regression analysis, the effect of the level of sleep disturbance (best, medium, worst sleep) on 
having migrated to another pain group at follow-up five years later was investigated. Best 
sleep was the reference category in the stratum `no pain’, and worst sleep was the reference 
category in the stratum `multisite pain’ (fig. 4).     
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Does sleep disturbance predict the 
direction of migration? 
 
Figure 4 Flow-chart describing the study design. Study II is designed to examine how 
individuals migrate from one stratum at baseline to a different one at follow-up. Does sleep 
disturbance predict the direction of the change in pain sites? 
 
The confounders considered in the study were: age, gender, BMI (dichotomised into <25 and 
>25 kg/m
2
), inclusion as case or referent in the MUSIC-Norrtälje study, smoking, physical 
activity, psychosocial exposure at work, and biomechanical exposures at work. The potential 
confounders were tested one by one in a stratified multinomial logistic regression analysis, 
and included in the modeling if, after adjustment for age and gender, they were significantly 
associated with outcome at a 0.05 level and altered the beta coefficient by more than 10%. 
The influence of the confounders differed across the strata. Age, gender, BMI, inclusion as 
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case or referent in the MUSIC-Norrtälje study, manual handling and prolonged sitting were 
included in at least one of the analyses.  
4.7.3 Study III 
The overall aim of study III was to investigate stress during everyday life in a natural setting 
and its association with changes in HRV measured during night time or decreased sleep 
quality the subsequent night and also to identify the possible influences of genetic and/or 
familial factors on such reactions. The following research questions needed to be answered: 
1) Does perceived daytime stress influence measures of night time HR and HRV?  
2) Does perceived daytime stress influence measures of sleep quality? 
3) Do genetic and/or familial factors influence any identified effects of daytime stress on 
night time HR, HRV or sleep quality? 
The study is cross-sectional, investigating the associations between stressors during the day 
and alterations in HR, HRV and sleep quality the subsequent night. It is designed to examine 
the effects of stressors occurring/being reported in an everyday life setting. Measurements 
were taken in the home environment, using simple one-item questions to quantify exposure.  
A set of three types of analyses was performed to investigate the above. 
First, the linear associations between the stress/potential health-related stressors and HR, 
HRV and Sleep quality were investigated to identify which stressors affected outcomes 
significantly under the conditions offered in study III. A marginal linear regression model 
was estimated from generalised estimating equations (GEEs) that take into account 
correlation within a twin pair. 
In a second set of analyses, the impacts of genetic and/or familial factors on the associations 
found at step 1 were investigated using within-pair analysis 
146
. The analysis was performed 
using the MIXED procedure, allowing for a random intercept for each twin pair.  
Within-pair analysis is a way of taking into account within-twin-pair similarities. This was 
achieved by including two independent variables, one for explaining differences in stress 
ratings within each twin pair (or more precisely, each twin`s difference from the twin-pair 
mean), and one for explaining the twin pair`s mean. Including a variable describing the 
difference in (stress) scoring within a twin-pair entails that even if a (male) twin rated his 
stress as very high, his value on the independent axis would be zero if his twin brother had 
exactly the same stress score. This would also be the case for a twin pair where both twins 
made exactly the same ratings, but very low ones. The two zeros would then contribute very 
little to describing the relationship between the x and y axis. By contrast, a pair where two 
twins rate their stress differently (a discordant pair) contributes more to the estimation of the 
relationship between the two axes. Two beta values are then interpreted for the regression. 
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One is estimated by within-pair differences in stress ratings (beta within) and one is estimated 
by the twin pair`s mean.  
Finally, in the third set of analyses, intra-class correlation and structural equational modeling 
(SEM) were used to investigate how much of the variance in the outcomes (HR, HRV and 
self-reported sleep quality) could be explained by heritability (A), shared environment (C) 
and unique environment (E), respectively. 
Intra-class correlation (ICC) coefficients were calculated by zygosity to determine whether, 
and if so to what extent, the monozygotic (MZ) twin pairs were more similar than the 
dizygotic (DZ) twin pairs. A SEM analysis was performed to partition the total variance of 
each HRV parameter, HR, and sleep quality respectively into components due to influences 
from genetic factors, environment shared within a twin pair, and an individual`s unique 
environment. In the models, the total variance is divided into additive genetic variance (A); 
dominant genetic variance (D); shared environmental variance (C), and unique environmental 
variance (E). The components are estimated in the models by comparing MZ twin pairs 
(assumed to share 100% of their additive and dominant genetic effects) and DZ twin pairs 
(assumed to share 50% of their additive genetic effects and 25% of their dominant genetic 
effects). The shared environmental effect is assumed to be equal for MZ and DZ twin pairs. 
The unique environmental effect is assumed to be explained by all other causes of the trait, 
including measurement error 
147
.     
Two separate models, ACE and ADE, were fitted for each variable using SEM, as too were 
the sub-models AE, CE, DE, and E. Parameter estimates as well as model fit statistics, -2 log 
likelihood, and Aikaike`s information criterion (AIC) values were calculated for each model. 
The fits of the model ACE and ADE were then compared by examining their AIC values (a 
lower value indicating better fit). The ACE model was estimated to have the best fit for all 
parameters. By log likelihood tests the fit of the nested sub-models AE, CE and E were tested 
against the full ACE model. A simpler sub-model (AE, CE or E) was preferred if it did not 
provide a significantly worse fit to data. Singleton twins were included in the analyses to 
enhance the precision of the estimated data. 
4.7.4 Study IV 
The aim of study IV was to investigate how many nights of measurement are needed for a 
reliable measure of sleep in a working population, including adult women and men, to be 
obtained. The measurements were performed in conjunction with the start-up of an 
intervention carried out by OHS, and thus in a “real life” setting.  
Sleep measurements were performed objectively with an actigraph, and subjectively with a 
sleep diary. Data were assessed for seven consecutive nights, including both weekday nights 
and weekend nights.  
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The analyses were stratified by gender to investigate potential gender differences in 
reliability. Also, two different conditions in the time-period setting were investigated, where 
one condition included weekdays only, and the other both weekend and weekdays.  
Also, the correlation between the actigraphic parameter sleep efficiency and self-rated sleep 
quality (indexed from the sleep diary) was calculated by Spearman correlation. The 
correlation was calculated for each day, ordered by study day and weekday, respectively.    
The intra-class correlation coefficient was calculated using a two-way random model, 
providing a ratio of the between-subject variance to the sum of all variance components 
148
. 
The intra-class correlation estimates the reliability of a measure of each parameter on a single 
night of measurement. A low single measure intra-class correlation indicates higher intra-
individual day-by-day variance in this study setting.   
The Spearman-Brown formula was then applied to estimate the effect of change in the 
number of aggregated days of measurement on the reliability of each test:  
RRSB=N*(ICC)/ (1+ (N-1) *ICC) 
A Spearman-Brown reliability coefficient of ≥0.7 was used to indicate acceptable reliability, 
in accordance with the previous literature 
77
.  
 
4.8 SUMMARY OF STATISTICAL METHODS 
Table 2. Statistical methods and software used in studies I-IV. 
Method Software Paper I Paper II Paper III Paper IV 
Logistic regression SPSS v. 19 x    
Multinomial logistic regression SPSS v. 19  x   
Generalized estimating equations  SAS v. 9.3    x  
Within-pair analysis SAS v.9.3   x  
Intra-class correlation SPSS v 22
a 
  x x 
Structural equation modeling  R, Open Mx   x  
Spearman correlation SPSS v.22    x 
a
 In paper III, SAS v. 9.3 was used. 
4.9 ETHICAL APPROVAL 
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and study IV: dnr 2013/677-31).   
 
   
29 
5 RESULTS 
5.1 Sleep and musculoskeletal pain 
Sleep disturbances were more common among participants who reported pain. In the group 
with concurrent LBP and NSP in study I, 46% belonged to the tertile in the full MUSIC 
cohort reporting worst sleep (Sleep C). In the group with multisite pain in study II, 38% 
reported Sleep C (table 3). 
 
Table 3. Proportions within each pain group from study I and study II reporting Sleep A (best sleep), 
Sleep B, and Sleep C (worst sleep). 
  Sleep A 
n (%) 
Sleep B 
n (%) 
Sleep C 
n (%) 
Study I No LBP or NSP (n=878)  419 (48) 251 (29) 208 (24) 
Solely LBP or NSP (n=799) 295 (37)  253 (32) 251 (31) 
Concurrent LBP and NSP (n=609) 148 (24) 183 (30)  278 (46)  
Study II No pain (n=188) 106 (56) 53 (28) 29 (15) 
Pain from 1-2 sites (n=530) 254 (48) 147 (28)  129 (24) 
Multisite pain (n=881) 262 (30) 281 (32) 338 (38)  
 
 
5.2 SLEEP, LBP/NSP AND SICKNESS ABSENCE 
Among the 2286 participants in Study I, the prevalence of sickness absence of >14 
consecutive days at some point between baseline and follow-up was 36%.  Within the group 
No LBP or NSP, the prevalence of sickness absence was 25% for >14 consecutive days, and 
10% for sickness absence of >90 days (defined as long-term sickness absence). In the group 
with solely LBP or NSP, the prevalence of sickness absence for >14 consecutive days was 
38%, out of which 18% had long-term sickness absence.  Among participants with concurrent 
LBP and NSP, the prevalence of sickness absence was 50%, out of which 25% had long-term 
sickness absence.  
Sleep had an effect on the odds ratio for sickness absence, and the odds ratio for sickness 
absence (>14 consecutive days) was significantly higher when Sleep C was compared with 
Sleep A within each pain group respectively. See table 4.   
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Table 4. The effect of sleep disturbances (Sleep A=best sleep; reference category, Sleep C=worst 
sleep) on sickness absence (>14 consecutive days), stratified by No LBP or NSP, Solely LBP or NSP 
and Concurrent LBP, presented by odds ratios (OR) and 95% confidence Intervals (95% CI). The 
results presented are after adjusting for age, gender, and physical illnesses. 
 No LBP/NSP 
OR (95% CI) 
Solely LBP/NSP 
OR (95% CI) 
Concurrent 
LBP/NSP 
OR (95% CI) 
Sleep A 1.00 1.00 1.00 
Sleep B 1.26 (0.87-1.83) 1.19 (0.82-1.71) 1.23 (0.79-1.93) 
Sleep C 1.59 (1.08-2.32)* 2.22 (1.55-3.18)** 1.62 (1.07-2.46)* 
*p<0.05; **p<0.01 
 
5.3 SLEEP AND MULTISITE PAIN 
In study II, the participants were grouped by number of self-reported pain sites at baseline 
into: 1) no pain, 2) pain from 1-2 sites, and 3) multisite pain (pain from ≥3 sites). The effect 
sleep had on whether individuals had migrated to a group with less or more pain sites at five-
year follow-up was investigated. Of the 1599 included in the study, 943 (59%) reported the 
same number of pain sites at baseline and follow-up, 16% had migrated to a group with fewer 
pain sites, and 22% reported more pain sites at follow-up than at baseline (fig. 5). 
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Figure 5. Number of participants in the different pain groups at baseline and whether or not they had 
migrated to different pain groups by the time of follow-up.    
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The results of the multinomial logistic regression analysis showed that sleep had an effect on 
the direction in which the participants migrated to a different pain group. Within the group 
with no pain at baseline reporting worst sleep (Sleep C), there was an OR of 4.55 (95% CI 
1.28-16.12) for reporting multisite pain at five-year follow-up compared with reporting best 
sleep (Sleep A), adjusted for age, gender and BMI. Within the group with multisite pain and 
best sleep (Sleep A) at baseline there was an OR of 3.96 (1.69-9.31 95% CI) for reporting no 
pain at follow-up, compared with worst sleep (Sleep C), adjusted for age, gender, inclusion as 
case or referent in the MUSIC-Norrtälje study, manual handling, and prolonged sitting. See 
figure 6.  
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OR (95% CI) 
Pain from 1-2 sites 
OR (95% CI) 
Multisite pain 
OR (95% CI) 
 
No paina Sleep A - ref ref 
Sleep B  1.43(0.70-2.90) 2.31 (0.66-8.09) 
Sleep C 
 
 0.90(0.34-2.40) 4.55 (1.28-16.12)* 
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Figure 6. Odds ratios (OR) and 95% confidence intervals (95% CI) for reporting an increased or 
decreased number of pain sites at follow-up. The effects of Sleep A (best sleep), Sleep B and Sleep C 
(worst sleep). Ref=Reference category for respective analysis. *p<0.05; 
a 
Adjusted for age, gender 
and BMI; 
b 
Adjusted for age, gender, and inclusion as a case or referent in the MUSIC-Norrtälje 
study; 
c 
Adjusted for age, gender, inclusion as a case or referent in the MUSIC-Norrtälje study, 
manual handling, and prolonged sitting. 
 
 
 
 32 
5.4 STRESS, HRV AND SLEEP QUALITY 
The results from paper III show that higher ratings on perceived stress during the day was 
significantly associated with altered night time HRV (SDNN, VLF and LF), higher HR ,and 
lower sleep quality the subsequent night (fig.7).  
Also, associations between the potential (health-related) daily stressors, hearing disabilities 
and tinnitus and HRV, HR and sleep quality were investigated in paper III. No associations 
between the health-related stressors and the outcomes were detected.  
In the within-pair analysis, taking within-twin-pair similarities into account among both MZ 
and DZ twins, the associations were attenuated, and no longer significant. The results indicate 
that changes in HR, HRV and sleep quality subsequent perceived stress during the day, are 
influenced by within-twin-pair similarities, i.e., genetic and shared familial environmental 
factors (fig. 7).   
Further, estimates of the proportions of heritability, shared environment and unique 
environment explaining individual variance on the HRV indices, HR and sleep quality were 
made using SEM.  The results show that heritability explained 33-49% of the variance of the 
HRV indices HF, LF, VLF, RMSSD, and SDNN. Variance in HR was influenced mainly by 
shared and unique environment, and variance in sleep quality was estimated to be influenced 
to 82% by factors related to unique environment, and to 18% by heritability factors. 
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Figure 7. Crude beta estimates and 95% 
confidence intervals describing associations 
between perceived stress and SDNN, VLF, 
LF, heart rate, and sleep quality. βC = 
Expected change in outcome for one unit 
increase in perceived stress; βW= Expected 
change in outcome for one unit increase in 
twin`s deviation from the twin-pair mean 
score on perceived stress.  ALL=All twins 
eligible for the analysis in question; MZ= 
Monozygotic twins; DZ= Dizygotic twins 
 34 
5.5 RELIABILITY AND GENDER DIFFERENCES IN SLEEP ASSESSMENTS 
In paper IV, some methodological concerns when performing sleep measurements, subjective 
and objective, were investigated. The correlation between objectively measured sleep 
efficiency and subjectively measured sleep quality was low overall and altered over the 
different days of the study. Over the different study days, the correlation was at its highest on 
day 2 (0.37), and lowest on day 7 (-0.02). Over the different days of the week, the correlation 
was highest on Thursday night (0.32) and lowest on Saturday (0.05).  
Through intra-class correlation using the Spearman-Brown formula, correlation coefficients 
were calculated for sleep measurements of one up to seven subsequent nights. The results 
show that the objective (actigraphic) sleep parameters, actual sleep (2 days), sleep efficiency 
(5 days) and fragmentation index (4 days), required fewer days of measurements for a reliable 
sleep measure than objective sleep duration (>7 days) and self-reported sleep quality (6 days). 
There were, however, gender differences in the reliability of the measurements. Sleep 
duration and sleep efficiency had the largest gender differences, and self-reported sleep 
quality and fragmentation the smallest gender differences (fig. 8). Including weekends in 
sleep measurements attenuated the reliability of all the sleep parameters as compared with 
only including week nights in the period of measurement (table 5). 
 
Table 5. Estimates for a single measure (ICC for a single measure, equivalent to the Spearman-Brown 
coefficient for a single measure) and the number of days of measurement (1 to 4) required for the 
reliable measuring of objective sleep parameters and subjective sleep quality. Results from when only 
week days are included in the period of measurement (Monday through Thursday) and from when 
weekend days are also included (Thursday through Sunday). When 4 days were not sufficient to reach 
reliability (a Spearman-Brown coefficient of >0.7), number of days required are presented in 
parentheses. 
 Mon through Thurs Thurs through Sun 
 ICC single 
measure 
Days 
required 
ICC single 
measure 
Days  
required 
Actual Sleep % 0.635 ≥2 0.480 ≥3 
Sleep efficiency % 0.449 ≥3 0.336 (>4) 
Fragmentation index 0.452 ≥3 0.404 ≥4 
Sleep durationa 0.386 ≥4 0.017 (>4) 
Sleep quality indexb 0.370 ≥4 0.206 (>4) 
a
 Sleep end – sleep start; b Self-reported sleep quality from sleep diary. 
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Figure 8. Presentation of Spearman-Brown 
coefficients (y-axis) by number of days of 
measurement (x-axis) for All (the full group, 
n=54); Women-only (n=25), and Men-only 
(n=29). Graphs 1-4 present sleep 
parameters from the objective actigraphic 
measures, and graph 5 subjectively reported 
sleep quality (indexed from the sleep diary). 
A coefficient >0.7 indicates satisfactory 
reliability. The Spearman-Brown coefficient 
for day 1 is equivalent to the ICC coefficient 
for a single measure.  
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5.6 ADDITIONAL ANALYSIS 
5.6.1 Sleep, pain and sickness absence 
Previous research has shown that pain intensity predicts poor prognosis of LBP 
108
 and 
increased risk of sickness absence in LBP and NSP 
149
. Thus, additional adjustments were 
made for pain intensity. Grouping was performed according to: 1) Solely LBP; 2) Solely 
NSP; 3) Concurrent LBP and NSP. The trend for pain intensity with different sleep 
disturbances showed small differences in pain intensity between Sleep A and Sleep C within 
all three pain conditions, with the largest difference in the group with concurrent LBP and 
NSP (table 6). After adjusting for pain intensity in the analysis investigating the odds ratio for 
sickness absence, the effect of sleep remained for the groups with solely LBP and solely NSP, 
not (just) for the group with concurrent LBP and NSP. The results show that sleep 
disturbances had a larger effect on sickness absence within the group with solely NSP as 
compared with the group with solely LBP, but the confidence intervals were rather wide 
(table 7).  
 
Table 6. The three levels of sleep disturbance among participants with solely LBP, solely NSP and 
concurrent LBP and NSP. Number of individuals (n), proportion (%) of sickness absence (sick. abs.), 
and mean pain intensity (pain int. 0-10). 
 Solely LBP   Solely NSP  Concurrent LBP and NSP 
 n % 
Sick 
abs. 
Pain int. 
Mean 
(sd) 
 n %  
Sick.  
abs. 
Pain  
int. 
Mean 
(sd) 
 n % 
Sick. 
abs. 
Pain int. 
Mean 
(sd) 
Neck/ 
low back 
Sleep A 190 31 4.2(1.6)  105 30 4.2(1.5)  148 41 3.8(2.0)/ 
4.3(1.6) 
Sleep B 147 37 4.1(1.5)  106 30 4.1(1.7)  183 47 4.3(1.9)/ 
4.4(1.6) 
Sleep C 133 47 4.5(1.8)  118 55 4.4(1.8)  278 56 4.7(2.0)/ 
4.8(1.8) 
Total n 470    329    609   
 
 
 
 
 
 
   
37 
Table 7. The effect of sleep on odds ratios (OR) and 95% confidence intervals (95% CI) for sickness 
absence ≥14 consecutive days, stratified into Solely LBP, Solely NSP, and Concurrent LBP and NSP. 
 
 
Solely LBP Solely NSP Concurrent LBP and 
NSP 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Model 1    
Sleep A 1 1 1 
Sleep B 1.31 (0.83-2.07) 1.00 (0.55-1.82) 1.25 (0.80-1.95) 
Sleep C 1.89 (1.19-3.00)** 2.83 (1.61-4.96)** 1.71 (1.14-2.58)* 
Age 1.01 (1.00-1.02) 1.02 (1.00-1.04) 1.01 (1.00-1.03) 
Gender 1.42 (0.97-2.10) 1.48 (0.88-2.48) 1.70 (1.20-2.40)** 
Model 2    
Sleep A 1 1 1 
Sleep B 1.31 (0.83-2.06) 1.01 (0.55-1.82) 1.21 (0.77-1.90) 
Sleep C 1.84 (1.15-2.92)* 2.80 (1.60-4.91)** 1.50 (0.99-2.30) 
Age 1.01 (0.99-1.03) 1.02 (1.00-1.04) 1.01 (1.00-1.03) 
Gender 1.42 (0.96-2.09) 1.46 (0.87-2.46) 1.56 (1.10-2.22)* 
LBP intensity 1.01 (0.99-1.02) - 1.01 (1.00-1.02)** 
NSP intensity - 1.01 (0.99-1.02) 1.02 (1.00-1.03) 
*p<0.05; **p<0.01 
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6 DISCUSSION 
The overall purpose of this thesis was to study markers of general stress as early indicators of 
changes in strain. Markers of this kind are assumed to be feasible measures to include when 
evaluating health outcomes in conjunction with interventions in clinical settings and 
workplaces.  
Work ability and sickness absence are relevant factors to consider in relation to health in a 
working population. When evaluating interventions it would be of value to use markers that 
indicate early general changes in wellbeing and risk of sickness absence. As a step towards 
identifying feasible markers of stress, this thesis has considered sleep disturbances and HRV 
during sleep. More specifically, sleep has been studied as a potential indicator of change in 
the risk of increased/decreased wellbeing (based on reported pain) and sickness absence. 
Further, the influence of genetic and/or familial environmental factors on indicators of 
prolonged stress responses after daytime stress (measured by HRV and sleep quality) has 
been investigated. The hypothesis is that changes in markers that indicate early signs of 
general stress predict general change in wellbeing and risk of sickness absence.  
6.1 MAIN FINDINGS  
In paper I and paper II participants were grouped by their pain status. By doing so, three 
contrasting groups with regard to pain (and baseline exposure) were investigated. In paper I 
sleep disturbances assessed by a global sleep questionnaire was found to indicate an increased 
risk of sickness absence among individuals free from spinal pain, among individuals with 
solely LBP or NSP, and among individuals with concurrent LBP and NSP. Further, sleep 
seems to tell us something about the prognosis of pain development. It was shown in paper II 
that worse sleep predicted the onset of multisite pain five years from baseline, and that 
sleeping well if having multisite pain predicted resolution from multisite pain five years later. 
Taken together, all this implies that having sleep problems is a factor indicating individual 
vulnerability to lower wellbeing. In both study I and study II, the study participants were 
grouped according to musculoskeletal pain. Having musculoskeletal pain may be considered 
a stressor and a vulnerability factor in itself. The overall results from study I and study II, 
based on the hypothetical model presented in fig. 3, are presented in fig. 9.  
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Figure 9. Model integrating results from paper I and paper II in the hypothetical model (fig.3, 
presented in the Background). Different pain status at baseline represents different baseline exposure, 
with individual risk of change (increased/decreased) in wellbeing. The present or absence of sleep 
disturbances is a marker of the individual risk of increased/decreased wellbeing (paper II) and 
decreased workability (paper I). 
 
As shown in paper III, individual differences in responses to everyday life stress, by 
suppressed sleep quality, increased HR, or differences in HRV, may be explained by factors 
related to familial similarities. This indicates that familial factors (genetic and/or shared 
environment) at least partly explain the individual differences in stress responses captured by 
sleep, HR, and night time HRV. In the search for a feasible prognostic marker to use in 
interventions, sleep has the advantage of being easy to measure and interpret. However, as 
shown in paper IV, when measured repeatedly over several subsequent nights, some 
methodological considerations arise. Objectively measured sleep (using an actigraph) 
requires fewer nights of measurement, especially if only measurements during weeknights are 
used, than subjectively measured sleep. However, objectively and subjectively measured 
sleep correlates poorly on a day-by-day basis, and it is likely that objective and subjective 
sleep measures capture different dimensions of sleep.     
(Paper I)  
Solely LBP or NSP; Concurrent 
LBP and NSP 
Individual risk of change in 
wellbeing 
Recovery 
from multisite 
pain 
Decreased workability  
(Sickness absence) 
Increased 
number of 
pain sites 
Individual risk of change in 
wellbeing 
(Paper II)  
No pain; Pain from 1-2 sites; 
Multisite Pain 
Sleep as a 
marker of 
general stress
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6.2 SLEEP AS A PREDICTOR OF WELLBEING AND SICKNESS ABSENCE 
In paper I, the effect of sleep disturbances on risk of sickness absence was investigated. The 
result implies that sleep disturbances increase the risk (OR) of sickness absence (of >14 
consecutive days) up to five years from baseline. The OR of sickness absence was 
investigated in three different groups: 1) people with no LBP or NSP; 2) people with solely 
LBP or NSP; and 3) people with concurrent LBP and NSP. The stratification was made under 
the presumption that it represents three separate groups with regard to wellbeing at baseline, 
assuming that the third group represents individuals with poorer wellbeing, and already at 
heightened risk of sickness absence.  
In all three groups, sleep had an impact on the risk of sickness absence. The effect of sleep 
was highest in the second group, with solely LBP or NSP. That sleep disturbances predict 
sickness absence is in line with the findings of previous prospective studies. In fact, out of 16 
identified studies 
11, 12, 33-45, 150
 only one presented a conflicting result 
150
.  
There seems to be only one previous study investigating the joint effect of sleep disturbances 
and musculoskeletal pain on risk of sickness absence. The results of this recent Finnish study, 
with one Norwegian and one Finnish cohort, were that comorbid insomnia and pain was more 
strongly associated with higher risk of sickness absence than solely insomnia or solely pain, 
which is in line with the finding in paper I 
36
.    
In a large prospective study, of 56,700 employees in Finland by Salo and colleagues 
12
, sleep 
disturbances were found to predict all-cause sickness absence, sickness absence due to mental 
disorders, diseases of the circulatory systems, and musculoskeletal diseases. Further, they 
found that poor sleep at baseline was associated with delayed return to work after a period of 
work disability due to musculoskeletal disorders (men and women), and due to mental 
disorders (men only) 
12
. In another study by Salo and colleagues 
39
, sleep disturbances were 
measured at two time points (with approximately two years in-between) and sickness absence 
of >9 days during the year subsequent to time point 2. The fully adjusted results from the 
study showed that fluctuating sleep disturbances (decreasing, or increasing) and stable 
moderate and stable severe sleep disturbances predicted all-cause sickness absence and 
sickness absence due to musculoskeletal disorders. Increasing sleep disturbances predicted 
sickness absence due to mental disorders, and stable severe sleep disturbances between the 
two time points predicted sickness absence due to injuries and poisonings 
39
.  Another large 
Finnish study, by Vahtera and colleagues 
44
, showed that individuals with sleep disturbances 
were more likely  to have sickness absence spells after a stressful life event (death or severe 
illness in the family) for up to 30 months after the occurrence of the event, as compared with 
individuals experiencing death or illness in the family who slept well 
44
. The results of the 
studies imply that sleep disturbances mark a vulnerability with a general increased risk of 
poorer wellbeing and workability, which is in line with what is suggested in this thesis.     
In paper II, number of pain sites was investigated as an indicator of wellbeing, both at 
baseline and at five-year follow-up.  A majority (69%) of people reporting multisite pain at 
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baseline also reported multisite pain at five-year follow-up (fig. 5). Only 6% of those 
individuals reporting multisite pain at baseline reported being pain free at follow-up. Sleep 
was shown to predict the prognosis of pain. Disturbed sleep predicted the onset of multisite 
pain assessed five years later among people who were pain free at baseline, and good sleep 
predicted the transition from multisite pain to no pain five years from baseline.  
In a recent study of Finnish firefighters with 13-year follow-up, sleep disturbances predicted 
the onset of radiating  LBP and membership of a group experiencing chronic radiating LBP 
throughout the study period 
151
. Sleep disturbances have further been shown to predict 
hospitalization due to back pain 
152
, the onset of chronic widespread pain 
153
, and increased 
number of  pain sites 
154
. That good sleep predicts the resolution of (at least chronic 
widespread) pain has also been shown previously 
126
, which supports the hypothesis that 
sleep predicts prognosis of musculoskeletal pain, as suggested in this thesis. Further, sleep 
problems among patients with persistent pain have been shown to predict depression in a 
recent British study by Campbell and colleagues. Pain interference (in people with normal 
work during the past 4 weeks) proved to have a significant, albeit minor, mediating effect on 
the relationship 
155
.        
6.2.1 Clinical significance 
Musculoskeletal pain disorders are often complex and recurrent by nature. It would be of 
great value to identify individuals at risk of poorer prognosis at an early state. Including sleep 
in the anamnesis when meeting a patient with musculoskeletal pain may be one strategy for 
identifying individuals at risk at an early stage. Further, sleep is reasonably easy to measure 
by questionnaire.  
Musculoskeletal pain and psychological illness are the two most common causes of sickness 
absence. Many patients affected become involved in rehabilitation programs, sometimes 
including workplace interventions under the regime of OHS. In handling these patients, it 
would be of great value to evaluate not only the progress of the specific disorder but also to 
include markers of wellbeing in a more general sense. Studies I and II suggest that sleep is a 
feasible general marker, indicating changes in wellbeing and risk of decreased workability.  
Moreover, the results presented above imply that it may be beneficial to have interventions 
that target sleep among patients with musculoskeletal pain and concurrent sleep disturbances. 
However, only a few studies have investigated such potential effects. Two studies that 
support beneficial effects of sleep interventions on pain have been found. One found that 
treating sleep problems with cognitive behavioural therapy among patients with 
musculoskeletal pain reduced pain intensity 
156
,  the other saw effects on pain interference 
with daily life 
157
.  Hopefully, more studies of this kind will be presented in the near future.   
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6.2.2 Methodological considerations 
The MUSIC-Norrtälje study (from which data for papers I and II were used) was a case-
referent study, where cases were included when people sought care for LBP or NSP. Thus, 
there was probably a higher prevalence of musculoskeletal pain in the cohort investigated in 
the two studies than there would have been in the general population. The studied cohort also 
probably included a larger proportion of individuals who had sought care for their pain than 
in the general population. Pain was self-rated, so some individuals recruited as referents also 
reported pain. Among those with “No LBP or NSP” in study I, 9% were recruited as cases, 
whereas within the groups “Solely LBP or NSP” and “Concurrent LBP and NSP”, the 
proportions were 57% and 66% respectively. In study II, 1% within the group “No Pain” 
were recruited as cases, 31% in the group with “1-2 pain sites” and 51% in the “Multisite 
pain group”. It has been suggested that individuals seeking care for their pain have worse 
pain, more disabling pain, and a poorer health status overall 
158
. Thus, the grouping may have 
led to the creation of groups that contrasted with each other with regard to more aspects of 
wellbeing than that induced by pain, which is considered a strength of the study. Sleep proved 
to predict sickness absence in all three group despite these differences.    
Further, both pain and sleep disturbances were self-reported, which may give rise to some 
problems in interpreting the results. Apart from capturing grade of pain and sleep 
disturbances, the scoring may also reflect individual tendencies to extreme or neutral scores. 
Even from this perspective, the stratification may have had a useful purpose.   
The benefit of grouping, i.e., obtaining three contrasting groups with regard to baseline 
wellbeing, however, was realised at the cost of reduced statistical power. This was seen above 
all in paper II, whose results are presented with very wide confidence intervals. Larger studies 
are needed to obtain more certain risk estimates.  
In paper I age, gender, physical illness (including cardiovascular, respiratory, gastrointestinal, 
urogenital and metabolic diseases), regular physical activity and smoking were included as 
potential confounders.  Other studies that have investigated  the association between sleep 
disturbances and sickness absence have also adjusted for emotional symptoms or mental 
illness (e.g., depression/anxiety) 
12, 33, 35, 38-45, 150
 as well as sociodemographic variables 
11, 12, 34, 
36-38, 40, 41, 43, 44, 150, 159
. Even though the effect of pain on the association between sleep and 
sickness absence was accounted for in most previous studies 
12, 33, 35-37, 40-42, 45
, only one 
investigated the separate and joint effects of pain and sleep disturbances (insomnia) on risk of 
sickness absence 
36
.  Unfortunately, for paper I, no variable measuring mental illness (that did 
not include sleep disturbances) was available.  Nor did the Finnish study investigating the 
joint effect of pain and insomnia on risk of sickness absence include mental illness as a 
covariate 
36
. In paper I and in this thesis, however, our main interest in sleep lay in its 
feasibility as a prognostic marker among individuals with increased risk of decreased 
wellbeing. Eliminating all other explanatory factors in a model, thereby leaving a model that 
explains causality was not the main focus of the thesis. Although sleep disturbances among 
individuals with musculoskeletal pain may be closely related to factors like ability to cope, 
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distress, anxiety, depression and worry about the future, responding with sleep disturbances 
may still be the marker of interest.  
Including pain intensity as a covariate in the additional analysis somewhat attenuated the 
effect of sleep disturbances on sickness absence in the stratum with concurrent LBP and NSP 
(OR 1.50; 95% CI 0.99-2.30), which resulted in a (just) non-significant OR. Pain intensity 
had, however, very little effect on the stratums including individuals with solely LBP or 
solely NSP (table 7). Pain intensity was a significant predictor of sickness absence for the 
stratum with concurrent LBP and NSP, but the effect was low (OR 1.01; 95% CI 1.0-1.02). 
The results imply that sleep disturbances are more closely related to perceived pain intensity 
among individuals with concurrent LBP and NSP than among individuals with solely LBP or 
solely NSP. The results also imply that sleep disturbances are a stronger independent 
predictor (i.e., independent of pain intensity) of poorer wellbeing and sickness absence in 
individuals with spinal pain from a single site.  
6.3 MARKERS OF STRESS AND INDIVIDUAL DIFFERENCES 
The markers of stress investigated in this thesis included sleep and HRV during sleep, so as to 
capture markers of prolonged daytime stress with potential health effects. There are most 
likely large individual differences in how we respond to stressful situations. McEwen 
7
 
regards these differences as dependent upon two principal factors: 1) Behaviour, how the 
individual perceives and interprets the situation, and 2) Biological mechanisms, that 
individual differences in reactivity are based upon genetic make-up, gender and 
developmental history 
7
. In paper III, individual differences in responses to everyday life 
daytime stress were investigated by considering the influence of genetic and/or environmental 
factors (shared within the family). The results show that when including the effect of genetic 
and/or familial environmental factors in models describing the relationship between 1) 
daytime stress and HRV during sleep and 2) daytime stress and sleep quality the subsequent 
night, the strength of the relationship is attenuated (fig. 7). The findings suggest that 
individual differences in vulnerability to daytime stress, captured by differences in sleep 
quality, HR or HRV during sleep (with the potential increased risk of negative health effects), 
are at least partly explained by genetic and/or familial environmental differences.  
Further, the estimated proportion of the variance in HRV, heart rate and self-reported sleep 
quality, attributed to heritability was investigated in paper III. Between 33-49% of the 
variance of HRV (except for the LF/HF parameter) and 18% of the sleep-quality variance 
were estimated to be explained by heritability. The influence of a heritability factor in the 
HRV and sleep quality parameters is supported also by the results of the intra-class 
correlation, where MZ twin pairs were found to be more similar on the HRV and sleep 
quality parameters than the DZ twin pairs. Between 67% and 51% of the variance in the HRV 
parameters and 82% of the variance of sleep quality were attributed to unique environmental 
factors (not shared within the family). The variability in heart rate was best estimated by a 
model including only environmental factors shared within the family and unique 
environmental factors, at a rate of approximately 50/50. However, after excluding individuals 
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using medications altering heart rate, the results came out differently; 58% of the variance in 
heart rate was explained by heritability, 42% by unique environmental factors. One 
explanation for the observed change in heritability after exclusion lies in loss of statistical 
power. Another possible explanation is that exclusion of individuals using the medications 
rules out an important group to investigate. If you select a sample of 50+ men not using beta 
blockers, antidepressants or anti-epileptics because you believe that use of those medications 
might alter HRV, you may have excluded an important group from the sample if depressed 
HRV actually has health effects.       
Altogether, the results in paper III indicate that some of the sustained reactions to daytime 
stress may be explained by heritability, which is supported by previous research. Heritability 
has been found to explain 29% (among women) and 43% (among men) of the variance in 
sleep reactivity to stress 
26
. Heritability of cardiovascular reactivity to stress has been 
investigated in the laboratory, investigating reactivity to acute stress, where 18-49% of the 
reactivity was seen to be explained by heritability 
160
.     
According to the results of study III, HRV (at least SDNN, VLF and LF), HR and sleep 
quality capture differences in daytime levels of stress. The perceived stress during the day in 
paper III was measured by a single item (“Have you felt stressed today?”) using a VAS (0-
100) scale. This item was chosen in order to capture stress or symptoms of stress in a global 
sense, without separating out work-related stressors, family-related stressors, worry, and 
other stressors. The question (or similar) is likely to be one of the most commonly used in 
clinical anamnesis, e.g., when meeting patients. The findings of paper III, that individual 
differences related to familial factors influence sustained stress response, fit well with the 
hypothesis that sleep disturbances and HRV during sleep are feasible markers of individuals’ 
vulnerability to stress.  
6.3.1 Clinical significance 
The results suggest that perceiving general (non-specified) stress during the day can be 
captured by changes in sleep quality and HRV the subsequent night. This suggests that both 
measures may be sensitive enough also to capture changes in everyday life stress. Both 
measures were influenced by genetics and/or familial factors related to the environment when 
growing up. It also suggests that sleep disturbances (and HRV during sleep) subsequent to 
daytime general stress not only is relative to the magnitude of the exposure, but also says 
something about the individual’s vulnerability to stress. Using sleep disturbances and/or HRV 
during sleep as markers of general stress with potential health effects may then be more 
informative than asking about stress (at least in one general question).      
The results, however, also point to difficulties in using HRV as a marker in clinical settings. 
Even though the method is interesting because of its ability to measure ANS activity 
relatively easily, there are still some difficulties in interpreting the physiological meaning of 
the HRV outcome. In study III, perceived stress was found to be associated with altered 
SDNN, VLF and LF, but not with RMSSD or HF. SDNN is a global measure of HRV, and 
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the physiological meaning of LF and VLF (with regard to sympathetic and parasympathetic 
tone) is still not entirely understood 
80, 81
. Further, the method is sensitive to other 
physiological responses, such as physical activity, and, even if the measurements are taken 
during sleep, it may be difficult to interpret the outcomes of the HRV variables at an 
individual level (at least as markers of stress). Sleep has the advantage of being easier to 
measure and interpret, and is therefore probably a more feasible marker in clinical settings. 
Moreover, sleep disturbances serve as a better indicator of how to intervene than HRV.  
6.3.2 Methodological considerations 
The study participants described in paper III differed from the other studied groups, in papers 
I, II and IV. In study III, all participants were men, and they were older, and most of them had 
retired from work. This probably affected the study results, and should be considered when 
interpreting their meaning for a general working population. A higher age is associated with 
decreased HRV 
161
, and being retired may have influenced the rates of perceived stress. 
Further, it has been suggested that prevalence of insomnia increases with age and is less 
common among men 
162
. In the twin study (with an older population), mean sleep quality was 
16.0, while in the SHIP study (including a working population, men and women), it was 16.7, 
indicating that the individuals in the SHIP study rated their sleep to be somewhat better.   
The purpose of using a single item, with VAS (0-100) scoring, to assess daytime stress was to 
capture general everyday life stress with a relatively continuous variable. If a scale with fewer 
rating steps had been used, there would have been less variance, which would have decreased 
statistical power. However, the clinical significance of the differences in stress ratings from 
this scale, with millimetre-wide scale steps, is difficult to interpret.  
Overall, the participants in study III scored rather low on the stress scale. The results may 
have come out differently if the study had included individuals with higher stress levels.   
6.4 SLEEP ASSESSMENTS 
There are different approaches to assessing sleep, and assessments differ according to the 
context in which sleep is of interest. A commonly used method to capture general sleep 
disturbances is to use questionnaires about how sleep typically has been during a particular 
past period of time. This approach was adopted for studies I and II in this thesis. If the interest 
lies in investigating how sleep was for one or a few specific nights, a sleep diary and/or 
objective measures (such as polysomnography or actigraphy) can be used. A sleep diary was 
used to assess sleep in paper III, capturing sleep for one night only. For paper IV, a sleep 
diary and actigraphy were used simultaneously to assess sleep repeatedly over seven 
consecutive nights.    
As well as choosing between a more general questionnaire regarding how sleep typically is 
and sleep assessments of one or several nights during a specific period of time, there are some 
methodological issues to consider. 
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First of all, do subjectively and objectively assessed sleep capture the same thing? In paper 
IV, the correlation between self-rated sleep quality and actigraphy-measured sleep efficiency 
was low overall, indicating that they do not completely translate into one another. Other 
studies have also found discrepancies between subjective and objective measurements of 
sleep, suggesting that they capture different dimensions of sleep 
72-74
. It has been found that 
going to bed late, use of medications, employment, higher body mass index (BMI), increased 
daylight hours and longer menstrual cycles are associated with poorer objective (actigraphic) 
sleep, and that unemployment and perceived stress are associated with poorer subjective sleep 
quality 
75
. Further, another study found that subjective sleep efficiency was associated with 
over-commitment, low level of social support, and poorer self-rated health, whereas objective 
sleep measures were not 
74
. 
Second, if repeated measures over a specific time period are of interest to assess, how many 
days of measurement would be required for a reliable measure of sleep? And does it matter 
which days of the week that are included in the measurements? Overall, the results from 
paper IV show that fewer nights of measurements are needed for actigraphy-measured sleep 
than for self-reported sleep. If measurements are performed during week nights only, fewer 
nights of measurement are needed for a reliable sleep measure than when including 
weekends; four nights would then be sufficient for both subjective (if using a sleep quality 
index) and objective (actigraphy) measurement. Previous studies have not found as large 
differences in sleep measurements between week nights and weekend nights as seen in paper 
IV 
75, 77
. This may be explained by different study populations (previous studies have 
included children and adolescents only 
77
 and women only 
75
). However, sleep during 
weekends may provide valuable information about recovery during leisure time.  
Sleep duration seem to be the parameter that differs the most on a day-by-day basis, 
especially when including weekend measures. It is reasonable to believe that if sleeping 
poorly or too few hours one night, people try to compensate for sleep loss by going to bed 
earlier the next night.  Previous studies have shown that a larger day-by-day variability in 
(actigraphy) sleep duration is associated with poorer subjective sleep quality, and poor 
subjective wellbeing 
163
 and stress 
164
.     
6.4.1 Clinical significance 
When sleep is to be measured as part of evaluating an intervention or in a clinical setting, 
there are some specific issues to take into account (as indicated in study IV). Actigraphy has 
the advantage of providing an objective measure of sleep, and is potentially more sensitive to 
capturing small changes in sleep after intervention. However, it seems that objectively and 
subjectively measured sleep capture different dimensions of sleep. Thus, there is the 
possibility that self-rated sleep is more strongly associated with some of the self-rated health 
effects of interest when evaluating an intervention.     
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6.4.2 Methodological considerations 
All participants in study IV were working in the same workplace, and may therefore be more 
homogenous than a random sample from a general population would be. Being in a study 
together with colleagues can also have increased compliance, which may explain the overall 
low proportion of missing data (90% had full actigraphy data). Previous studies have found 
up to 28% missing data on weekly recordings with actigraphy 
77
.  
Repeatedly responding to the same questionnaire for seven subsequent days may have 
influenced the results, which is worth considering when performing measurements of sleep 
repeatedly in the field. The respondent`s attitude to and interpretation of the questions may 
not be the same on the first day as when responding to the same questionnaire the fifth or 
sixth time. From this perspective, having an objective complement to subjective sleep 
measures when they are performed repeatedly can be of value. 
Future prospective studies should investigate whether objective and subjective sleep differ 
with regard to how they predict health outcomes.  
6.5 DISCUSSION OF THE INCLUDED STRESS MARKERS AND FEASIBILITY 
IN THE FIELD 
In order to maintain a healthy workforce, it is reasonable to believe that interventions 
targeting a workplace at group level, as well as at individual level, are of importance. The 
markers investigated in this thesis were chosen based on the hypothesis that they were 
feasible in field when performing repeated measurements to capture changes at a group level. 
In all, four different ways of assessing markers of stress have been used in this thesis:  
 A sleep questionnaire measuring global sleep disturbances (sleep disturbances over 
the past six months) (papers I and II) (subjective) 
 Sleep quality for one specific night (by sleep diary) (papers III and IV) (subjective) 
 Objective measure of sleep by actigraphy (paper IV) (objective) 
 HRV and HR during sleep (paper III) (objective) 
Subjective measurements: A questionnaire for the assessment of global sleep disturbances by 
referring to the recent period of time have the advantages of being easy to distribute to a large 
group and easy to extract data from. One possible advantage of a global measure of sleep is 
that it can distinguish short-term periodic sleep disturbances from long-term or recurrent 
disturbances. It is possible that the tendency repeatedly to suffer from sleep disturbances is a 
more informative indicator of general stress than a short period of sleep loss (captured when 
assessing sleep over a shorter specific period of time) followed by recovery.          
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However, if changes over shorter periods of time are of interest, measurements during some 
specific days may be preferable. Then, a subjectively measured sleep diary, an objective 
actigraph, or objective HRV over a set of specific nights may be feasible options.  
The subjective sleep diary is easy to distribute and easy to extract data from.  
Objective measurements: An actigraph may be a feasible objective complement to 
subjectively measured sleep. The actigraph is also easy to distribute and relatively easy to 
extract data from. One advantage of the actigraph is that it can be administered at a distance. 
This was tested in study IV, where actigraphs were uploaded at the researcher`s office, then 
distributed to the study participant, together with simple instructions for use via the 
workplace.  
The HRV measure is relatively easy to administer, and the device can be attached in the field, 
although it requires a computer to start measurement. The disadvantage of HRV is that it is 
rather time-consuming to extract data from. There are some technological issues to consider, 
e.g., which software program to use and how to handle noise in the data. From the 
experiences of assessing data in study III (HRV) and study IV (actigraph), the risk of (at least 
partly) missing data due to technical issues (or, for example, episodes with bad electrode 
contacts) is higher with HRV. Further, even though changes in HRV may be seen at group 
level, interpretation of the physiological meaning of the data is difficult. Another advantage 
of sleep measurement as compared with HRV measurement is that sleep is easier to influence 
at individual level, e.g., with cognitive behavioural therapy 
156, 157
.    
Both the associations between everyday life stress and HRV, and everyday life stress and 
sleep quality, were influenced by factors related to genetics and/or familial environment (at 
least in the group with overall relatively low stress scores, as seen in paper III). This 
knowledge is of importance when interpreting the data assessed, i.e., in order to understand 
why, at group level, changes are seen among some, but not others.   
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7 SUMMARY AND CONCLUSIONS 
 
 Disturbed sleep predicted sickness absence for up to five years from baseline. This 
was seen within all three groups with different baseline exposures (wellbeing/stress) 
1) No LBP or NSP, 2) Solely LBP or NSP, and 3) Concurrent LBP and NSP.  
 
 Disturbed sleep predicted the onset of multisite pain five years later in a group 
reporting no pain at baseline.  
 
 Good sleep predicted migration from a group with multisite pain at baseline to 
reporting no pain at five year follow-up. 
 
 Daytime stress influenced changes in HRV measures and sleep quality the subsequent 
night. 
 
 Responding with changes in HRV during sleep or decreased sleep quality to 
perceived daytime stress was seen to be influenced by factors related to genetic and/or 
early familial environmental factors. 
 
 Some issues need to be taken into account when performing a sleep measurement, 
depending on the context. If performed repeatedly over several consecutive nights, at 
least four nights of measurement are recommended to obtain a reliable measure, for 
both actigraphy and subjective sleep quality.  
 
 There seems to be a difference between sleep measurements taken over weeknights 
and weekend nights. If a set of measurements includes weekend nights, more 
(consecutive) nights of measurement are needed for a reliable measure. 
 
 Objective sleep measurement (using a wrist-worn actigraph) is easier to administer, 
easier to interpret, and less time-consuming than HRV measurement, and may 
therefore be more feasible in the field.   
7.1 FUTURE RESEARCH 
More research is needed to understand the feasibility of sleep as an early marker of wellbeing 
and stress. One way would be to test the ability of sleep measurements (objective and 
subjective) to capture repeated small changes at several time points before, during and after 
an intervention. Moreover, the impacts of these changes in sleep patterns on different health 
outcomes need to be investigated further.  
Further, it would be interesting to pursue research aiming to increase our knowledge on level 
of prolonged stress and reactivity to stress (i.e., to investigate whether stress exposure is 
transformed into a response that is associated with harmful health effects). 
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Further research is needed better to understand the difference between subjective and 
objective sleep. Prospective studies investigating differences in what (health outcomes) the 
two methods predict are welcome. Also, more knowledge is needed to understand the effect 
of responding more than once to the same questionnaire (e.g., over several subsequent 
days/nights). What does it really measure?  
Potentially, interventions targeting sleep (e.g., cognitive behavioural therapy) may be relevant 
as complements to traditional therapy targeting pain disorders. More research is needed to 
understand the effect of such interventions on recovery from pain disorders. 
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